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 During colonization of the cystic fibrosis airway Pseudomonas aeruginosa 
converts from non-mucoid to a mucoid phenotype, characterized by the production of 
the exopolysaccharide alginate. Alginate production has been shown to enhance 
survival by promoting biofilm formation, evading complement killing, and resisting 
phagocytosis. The mechanism by which alginate protects P. aeruginosa from 
phagocytosis is unclear. To investigate the role of alginate in the inhibition of 
phagocytosis, a human monocytic cell line (THP-1) and a murine alveolar macrophage 
cell line (MH-S) were used to determine the effects of alginate on macrophage binding, 
  
signaling, and phagocytosis. Phagocytosis assays using the mucoid cystic fibrosis 
clinical isolate FRD1, and its non-mucoid isogenic algD mutant FRD1131, revealed that 
alginate inhibits opsonic and non-opsonic phagocytosis. The inhibitory effect of alginate 
production is intrinsic to the bacteria as exogenous alginate was unable to protect non-
mucoid FRD1131 from phagocytosis. Decreased binding of FRD1 compared to 
FRD1131 was also demonstrated by using the actin polymerization inhibitor 
cytochalasin D to inhibit phagocytosis. Furthermore, studies using blocking antibodies to 
CD11b and CD14 found that both of these receptors were important for the 
phagocytosis of FRD, and it is likely that these receptors are blocked by alginate. 
Alginate production by P. aeruginosa may reduce lipid raft formation, however, it was 
not found to affect acid sphingomyelinase activity, which is important for ceramide 
formation within the lipid raft. Decreased binding led to decreased signaling in 
macrophages demonstrated by reduction in level and alteration in kinetics of 
phosphorylation of AKT and ERK1/2 kinases. Signaling pathway inhibitors revealed that 
PI3K, but not MEK, activation was critical for phagocytosis of P. aeruginosa. Despite 
altered intracellular signaling in murine macrophages, both mucoid and non-mucoid P. 
aeruginosa induced similar levels of IL-8 and MIP-2 from human and murine 
macrophages, respectively. By understanding the pathways involved in mediating 
efficient phagocytosis of clinical isolates, it may be possible to develop a treatment to 
promote clearance by the resident alveolar macrophages. These experiments may 
serve as a model to evaluate the effectiveness of such treatments. This approach also 
provides valuable insight into previously unknown mechanisms of phagocytosis of P. 
aeruginosa.
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Chapter 1 
Introduction 
 
 
 
Pseudomonas aeruginosa 
 Pseudomonas aeruginosa is a gram-negative, biofilm forming, aerobic rod. P. 
aeruginosa is commonly found throughout the environment in soil, surface water, 
sewage, plants, and foods (70). While it is a common human intestinal bacterium, P. 
aeruginosa is an opportunistic pathogen, which is responsible for a variety of infections 
(70). These infections include keratitis, skin infections, urinary tract infections, infections 
of the upper and lower respiratory tract, and of the bloodstream (45). 
Immunocompromised patients as well as those on mechanical ventilation are at risk of 
serious infections by P. aeruginosa (70). Immunocompromised patients include those 
with cancer or HIV infection, transplant recipients, and burn patients. Nosocomial 
infection by P. aeruginosa presents an important risk for these patients as it increases 
the mortality rate by 40% (70). Recent studies have found that while the chance of P. 
aeruginosa infection in U.S. hospitals is 4%, it is responsible for 10% of all hospital-
acquired infections (HAI) (70). Acute infection of the respiratory tract by P. aeruginosa 
often leads to septic shock, multiple organ dysfunction, and has a mortality rate of up to 
48% (70). Chronic infection of the airway is very different from acute infections. Chronic 
infection of the airway of cystic fibrosis (CF) patients causes significant inflammation 
and tissue damage, which is a major cause of morbidity and mortality (70). P. 
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aeruginosa infection is very common among patients with cystic fibrosis and is currently 
found in 58% of all patients. P. aeruginosa strains isolated from patients with CF are 
phenotypically different from those isolated from the environment and these adaptations 
promote survival by allowing P. aeruginosa to evade the host immune system. CF 
strains often lack flagellin and pilin expression. These CF adapted strains also produce 
‘rough’ lipopolysaccharide (LPS), which does not have the long O-side chains 
characteristic of ‘smooth’ LPS (70). This change in LPS structure could alter the innate 
immune response by affecting binding to phagocytes and inflammatory signaling. 
 P. aeruginosa virulence factors include antibiotic resistance, biofilm formation, 
alginate production, and secreted effectors. Clinical isolates have been found to have 
pathogenicity islands which directly contribute to virulence. Secreted effectors such as 
elastase, alkaline proteases, hemolysins, cytotoxins, and siderophores promote tissue 
invasion. These effectors also protect against the innate and adaptive immune system 
by cleaving important receptors, signaling molecules and by inactivating complement 
and antibodies (16, 70). P. aeruginosa also produces pyocyanin, which has a 
proinflammatory effect in the lungs of CF patients. Pyocyanin also disrupts antioxidant 
functions within the lung which leads to oxidative damage to the lung epithelium (70). P. 
aeruginosa also secretes several effector proteins via a type III secretion system 
including ExoS, ExoT, ExoU, and ExoY (16). Type III secretion involves a molecular 
nanomachine to inject effectors directly into target cells (16). These effectors are known 
to disrupt intracellular signaling, which can affect phagocytosis and inflammation (9, 16). 
For example, ExoS has been shown function as a GTPase-activating protein (GAP) to 
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stimulate GTP hydrolysis by RhoA, which regulates cytoskeletal rearrangement and is 
involved in PI3K-mediated signaling pathways (9, 16, 22). 
 
Pseudomonas aeruginosa infection in cystic fibrosis 
 A large amount of research is directed at P. aeruginosa respiratory infections in 
patients with cystic fibrosis. Cystic fibrosis is an important respiratory disease that 
affects 70,000 people worldwide with 1000 people being diagnosed every year (12). CF 
is an autosomal recessive disease caused by a mutation in the cystic fibrosis 
transmembrane conductance regulator (CFTR) gene, which produces a cyclic AMP-
regulated chloride ion channel (18). Over 1,500 possible mutations in the CFTR gene 
have been identified, typically leading to the production of a non-functional, and 
subsequently degraded, protein (18, 36, 72). The loss of the channel results in defective 
chloride ion transport, which has many systematic effects including the production of 
highly adhesive mucus (67). This altered mucus production inhibits bacterial clearance 
and promotes respiratory infections. A recent study found that 97% of children with CF 
were colonized with P. aeruginosa by the age of 3 years and that among all patients 
over 58% were infected with P. aeruginosa (70). P. aeruginosa infection in CF is 
associated with increased morbidity and mortality (29). Due to the widespread presence 
of P. aeruginosa in the environment and the high incidence of hospital acquired 
infections, it is important to understand the survival mechanisms responsible for its 
persistence within the CF lung (31, 70). 
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Alginate regulation and synthesis 
 P. aeruginosa produces three extracellular polysaccharides called Psl, Pel, and 
Alginate. Psl is produced by a fifteen-gene operon and is important for attachment as 
well as the maintenance of biofilm structure (69). Psl was found to be required for 
adherence to mucin-coated surfaces and airway epithelial cells. Pel is a glucose-rich 
matrix polysaccharide produced by a seven-gene operon (69). Pel is important for 
pellicle formation and biofilm structure, similar to Psl. However, Pel is biochemically and 
genetically distinct from Psl. During colonization of the CF airway, P. aeruginosa 
converts from non-mucoid to a mucoid phenotype, characterized by the production of a 
capsular exopolysaccharide alginate (13, 46). High levels of alginate have been 
measured in the sputum of patients with CF who are chronically infected with P. 
aeruginosa (18). Alginate is composed of D-manuronate and L-guluronate, of which the 
D-manuronate is O-acetylated. The P. aeruginosa alginate operon is composed of 12 
genes controlled by a single promoter, which is ultimately regulated by σ22 (AlgT/U) 
(34). σ22 activation leads to the production of AlgR, AmrZ and AlgB, which bind to the 
alginate promoter allowing for transcription. σ22 is negatively regulated by the 
membrane bound anti-sigma factor, MucA. The conversion from non-mucoid to mucoid 
phenotype may be caused by many factors including cell wall stress and oxygen 
radicals (11, 13, 53, 87). 
 Alginate synthesis begins in the cytoplasm and modifications continue while it is 
transported through the inner and outer membranes (34, 35). Alginate production 
begins with fructose-6-phosphate, a common sugar generated during glycolysis. 
Fructose-6-phosphate is rearranged by the phosphomannose isomerase activity of AlgA 
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producing mannose-6-phosphate. Phosphomannose mutase, produced by algC, then 
moves the phosphate group on mannos-6-phosphate to form mannose-1-phosphate. 
The GDP-mannose phosphorylase activity of AlgA uses mannose-1-phosphate, along 
with the cofactor GTP, to form GDP-mannose. GDP-mannose dehydrogenase, 
produced by algD, then oxidizes the C6 hydroxyl group of GDP-mannose to a carboxylic 
acid to form GDP-mannuronic acid. GDP-mannuronic acid is then transported across 
the inner membrane by the polymerase, produced by alg8. During this processes GDP-
mannuronic acid is polymerized by Alg8 with the help of Alg44 to form 
polymannuronate. Polymannuronate is then epimerised at the C5 carbons by D-
mannuronate C5-epimerase, produced by algG, to form a polymer of D-mannuronate 
and L-guluronate subunits. D-mannuronate subunits are O-acetylated by a complex 
formed by AlgI, AlgJ, and AlgF. The O-acetyltransferase, produced by algI, transfers an 
acetyl group from acetyl-CoA across the inner membrane to AlgJ and AlgF, to be added 
to D-mannuronate. The acetylated D-mannuronate-L-guluronate polymer is transported 
across the periplasm with the help of several scaffold proteins produced by algX, algL, 
and algK. AlgE, recruited by AlgK, forms a porin in the outer membrane to export the 
alginate that has been transported across the periplasm (34, 35, 39, 60, 66). 
 Mucoid conversion of P. aeruginosa in the CF airway is a slow process; 
therefore, alginate production is not likely to be responsible for the initial immunological 
failure leading to infection and colonization of the CF lung by P. aeruginosa. However, 
alginate production by mucoid P. aeruginosa may contribute to maintenance of the 
chronic infection by inhibiting its clearance by alveolar macrophages. Alginate 
production has been shown to enhance survival through various means including 
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promoting biofilm formation and evading complement killing (6, 8, 43). σ22 has also been 
shown to promote expression of AmrZ, which inhibits the master regulator of flagellum 
expression, FleQ (78, 79). 39% of P. aeruginosa CF isolates were found to be non-
motile and several studies have shown that the non-motile phenotype may enhance the 
survival of P. aeruginosa in the CF lung by evading phagocytosis (1, 47, 50, 51). It has 
been reported that mucoid P. aeruginosa is resistant to opsonic and non-opsonic 
phagocytosis, and that alginate production by P. aeruginosa confers protection against 
IFN-γ mediated opsonic killing of a P. aeruginosa biofilm (8, 43, 46, 63, 68). There are 
low levels of opsonins found in the lung environment, and the effects of alginate 
production on phagocytosis by macrophages in a serum-free environment have not 
previously been extensively studied (29). 
 
Phagocytosis 
 Phagocytosis is an actin-dependent process that involves the use of multiple cell 
surface receptors to bind pathogens and cell debris (16, 84). Macrophages also extend 
actin-dependent projections to search the surrounding environment for pathogens (16). 
This internalization requires a complicated series of membrane remodeling, cytoskeletal 
rearrangement, and intracellular signaling events. The result of these events is the 
formation of a phagosome, the engulfment of the pathogen, and the release of 
inflammatory cytokines. Multiple receptors come together and form multimers within 
lipid rafts to enhance binding capacity. This is necessary because bacterial movement, 
due to Brownian motion and flagellar motility, will cause the bacteria to detach if there 
are only low affinity interactions (16). 
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 Phagosome formation begins with an increase in phosphatidylinositol-4,5-
bisphosphate (PI(4,5)P2) concentration in the cell membrane. Phosphatidylinositide 3-
kinase (PI3K) stimulates phospholipase C (PLC)-γ which modifies PI(4,5)P2 into 
phosphatidylinositol-3,4,5-trisphosphate (PI(3,4,5)P3) until the phagosome has sealed. 
After sealing, PI(3,4,5)P3 is once again modified to become phosphatidylinositol 3-
phosphate (PI(3)P) which is the primary lipid in early phagosomes (16). These early 
phagosomes bind to early endosomes and eventually late endosomes and lysosomes 
to form late phagosomes and late phagolysosomes (16). This results in the acidification 
of the phagosome and destruction of the pathogen. 
 Phagocytosis involves two broad categories of receptors, opsonic receptors and 
pattern-recognition receptors. Opsonic phagocytosis requires receptors that bind an 
intermediary molecule which binds to the target bacteria. Opsonic receptors include Fc 
receptors such as FcγRI, FcγRII, and FcγRIII and complement receptors such as CR1, 
CR3 (CD11b/CD18, MAC-1), and CR4 (CD11c/CD18) (16). For opsonic phagocytosis 
Fcγ receptors bind various IgG antibodies, while complement receptors bind mannan-
binding lectin (MBL) and various complement fragments. However, further research has 
revealed that these opsonic receptors are also capable of binding bacterial ligands 
directly and that these interactions are critical for host defense. For example, 
complement receptor 3 is able to bind numerous ligands including LPS, LPG 
(lipophosphoglycan), acylpolygalactoside (APG), β-glucans, intercellular adhesion 
molecules (ICAM)-1, ICAM-2, ICAM-3, β-amyloid, high mobility group box 1 (HMGB1), 
and oligodeoxynucleotide (7, 89). As a result, CR3 has been found to be important for 
cellular binding and internalization by murine macrophages (27). Pattern-recognition 
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receptors recognize a broad range of pathogen-associated molecular patterns 
(PAMPs). These receptors include Toll-like receptors (TLR) and scavenger receptors 
(SR) which are also critical to host defense (16, 84). Both SR-A and TLR-4 (with CD14) 
are able to bind LPS (16). However, it is possible that alterations to LPS structure may 
result in altered signaling through these receptors. Several macrophage receptors have 
been implicated in the phagocytosis of P. aeruginosa. These receptors include TLR2, 
TLR4, TLR5, mannose receptor (MR), CR3, CR4, SR-A, MARCO and Fc receptors (4, 
16, 29, 38, 70, 74). However, the contribution of each receptor varies depending on the 
P. aeruginosa strain that is used. Although, antibodies to alginate are generated by CF 
patients with chronic P. aeruginosa infections, these antibodies have been shown to be 
unable to mediate opsonic killing in vitro (69). 
 Phagocytosis plays an important role in clearing cell debris, including apoptotic 
cells (16). Phosphatidylserine (PS) is a lipid that is restricted to the inner leaflet of the 
plasma membrane. Apoptosis exposes this lipid as a marker for clearance. MFG-E8 
(lactadherin) binds PS which is then bound by several phagocytic receptors including 
αVβ3 integrin, CD36, and CD68 (16). While phagocytosis of pathogens induces the 
production of inflammatory cytokines, phagocytosis of apoptotic cells induces anti-
inflammatory cytokines to prevent tissue damage (16).  
 Activation of the above receptors results in the activation of a wide range of 
interconnected signaling pathways that lead to the formation of the phagocytic cup and 
the release of inflammatory cytokines and chemokines. Efficient phagocytosis of P. 
aeruginosa is dependent on PI3K signaling, leading to the phosphorylation and 
activation of certain signaling molecules, such as AKT and NF-kB (37). NF-κB is a 
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transcription factor that is activated when the inhibitor of NF-κB alpha (IκBα) is 
phosphorylated, leading to its degradation (42). Once free from IκBα, NF-κB 
translocates to the nucleus and promotes the expression of inflammatory cytokines 
including IL-8, TNF-α, and IL-6. AKT inhibition has resulted in inhibited phagocytosis of 
PAO1 by murine macrophages (37). ERK activation may also contribute to 
phagocytosis of P. aeruginosa as it has been shown that ERK activation leads to 
phosphorylation of myosin light chain kinase (MLCK) in polymorphonuclear leukocyte 
(PMNL) and epithelial cells (52, 58). Phosphorylation of MLCK leads to actin 
rearrangement, which is necessary for the formation of the phagocytic cup. Actin 
rearrangement during phagocytosis is also dependent on the Rho GTPase Rac (16). 
Prior to these signaling events, ceramide accumulation and lipid raft formation within the 
phagocytic cup may also be critical to the phagocytosis of P. aeruginosa (23).  
 
The macrophage response to Pseudomonas aeruginosa in the cystic fibrosis 
lung 
 Significant numbers of macrophages are found in the CF airway (2). However, 
macrophages isolated from P. aeruginosa infected CF patients exhibit a M2 phenotype, 
which can mediate chronic inflammation (28). The mechanism by which alginate 
protects P. aeruginosa from opsonic and non-opsonic phagocytosis is unclear. When 
the murine macrophage cell line RAW264.7 is exposed to alginate, production of 
inflammatory cytokines, such as TNF-α and Interleukin 6 (IL-6), are up-regulated (88). CF 
is also associated with increased Interleukin 8 (IL-8) production within the lung (77). 
This suggests that alginate is able to affect macrophage activation, which could affect 
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inflammatory cytokine production in the CF airway. The CFTR mutation may further 
complicate inflammatory signaling within the CF lung. A mutation in the CFTR gene has 
been shown to lead to an up-regulation of inflammatory cytokine production by airway 
epithelial cells (49). Inflammatory cytokines released by epithelial cells, and to a lesser 
extent macrophages, exacerbate the disease by recruiting large numbers of neutrophils 
to the airway and causing tissue damage (11). This is likely due to constitutively active 
NF-kB (49). The recruited neutrophils are unable to clear the infection and further 
contribute to the disease by providing a DNA and F-actin rich environment for P. 
aeruginosa growth (6). P. aeruginosa utilizes polymers of DNA and F-actin, provided by 
the neutrophils, to form biofilms in the CF airway (86). These neutrophils are also a 
source of oxygen radicals, which may induce mucoid conversion in P. aeruginosa (53). 
 
Scope of this project 
 Understanding how alginate production by P. aeruginosa leads to enhanced 
survival in the context of the CF lung is important for the treatment of CF lung infections. 
By understanding which receptors and signaling pathways are critical to the 
phagocytosis of mucoid P. aeruginosa, it may be possible to stimulate the alveolar 
macrophages to enhance clearance of an established infection. Prior to this 
dissertation, the mechanism by which alginate inhibits macrophage phagocytosis of P. 
aeruginosa was not well characterized. This was accomplished by using a combination 
of microbiological and immunological assays to determine the role of alginate in 
inhibiting phagocytosis. 
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 To address this problem, I first determined the effect of alginate on opsonic and 
non-opsonic phagocytosis by human and murine macrophages. I found that alginate 
was able to inhibit phagocytosis in both types of macrophages, under opsonic and non-
opsonic conditions. I followed this up by determining how and when alginate is able to 
inhibit phagocytosis, as well as determining how other factors influence phagocytosis of 
P. aeruginosa. This revealed that alginate production has a local inhibitory effect by 
blocking binding to the macrophage. I continued by investigating the inhibitory effect of 
alginate on macrophage receptor binding, intracellular signaling, and extracellular 
signaling. This revealed important phagocytosis receptors, the blocking of which causes 
altered activation of critical phagocytosis signaling pathways and reduced phagocytosis. 
This research could provide important information leading to a better understanding of 
the chronic lung infection in CF as well as providing information on the mechanisms 
involved in the phagocytosis of P. aeruginosa by human and murine macrophages. 
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Chapter 2 
Materials and Methods 
 
 
 
Bacterial culture media and growth conditions 
 All Pseudomonas aeruginosa and Escherichia coli strains were grown on Luria-
Bertani (LB) agar plates. Following growth on solid media, all strains were grown in LB 
liquid media at 37°C with shaking. Antibiotics were used when necessary for plasmid 
maintenance at the following concentrations: ampicillin, 100 µg/ml; carbenicillin, 150 
µg/ml; kanamycin, 30 µg/ml. 
 
Bacterial strains and plasmids 
 The bacterial strains used in this study are described in Table 1. Plasmids used 
in this study are described in Table 2. FRD1 is a cystic fibrosis clinical isolate in which 
alginate production is constitutively active due to a mucA mutation, which prevents 
MucA from sequestering σ22. FRD1131 is an isogenic mutant of FRD1 that contains an 
algD::Tn501-33 mutation. algD is the first gene in the alginate operon and the 
transposon is polar on all downstream genes, so FRD1131 is unable to produce 
alginate, regardless of σ22 regulation. PAO1 is a clinical wound isolate that does not 
produce alginate. PDO300 is a PAO1 mucA mutant in which alginate production is 
constitutively active. 
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 GFP-expressing strains were constructed by transfering pMF230 into the 
recipient strain by conjugation. The mCherry plasmid was constructed by PCR 
amplifying the gene from pMP7605 with the following primers: 5’-
gatcaagcttttacttgtacagctcgtccat-3’ and  
5’-gatctctagaatggtgagcaagggcgagg-3’ (44). DNA was ligated to the pMF54 plasmid, a 
broad-host range expression vector, and transformed into competent DH5α cells. The 
completed plasmid was then transferred into the recipient strains by conjugation. 
 For purposes of judging multiplicity of infection (MOI) for all experiments, colony 
counts were used. Overnight cultures of bacterial strains were diluted 1:10 and grown 
for 2 hours until mid-log phase growth (0.8 at OD600). 1 ml of each strain was 
centrifuged at 14,000 RPM for 3 minutes. Supernatants were removed and the pellet 
was resuspended in 1 ml of RPMI. The number of resuspended bacteria was 
determined by serially diluting 100 µl 1:10, and spreading 100 µl of the dilutions on LB 
agar plates. After overnight incubation at 37°C, colonies were counted to determine 
colony forming units (CFU). This CFU count was used to determine the MOI for 
subsequent experiments. 
 
Strain construction 
Sequence-defined transposon insertions in PAO1 from a mutant library were moved by 
transduction to PAO and FRD strains (30). Phage F116L plate lysates were made on a 
library mutant. The filter sterilized lysate was incubated for 4 hours with the recipient 
strain and then plated onto LB-agar with tetracycline (100 µg/ml) to select for 
inheritance of the transposon by homologous recombination.  
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Macrophage culture 
 THP-1 and MH-S macrophages were purchased from ATCC (TIB-202 and CRL-
2019, respectively) and grown in complete RPMI containing 10% FBS (Gibco), 1% 
penicillin and streptomycin, and 1% L-glutamine. Cells were counted by hemocytometer 
prior to plating for each experiment. THP-1 macrophages were differentiated with 12-O-
tetradecanoylphorbol-13-acetate (TPA) (Sigma, final concentration 3.2 x 10-7 M) for 2 
days prior to infection experiments (82). 
 
Flow cytometry based phagocytosis assay 
2x105 THP-1 or MH-S macrophages were grown in 12-well plates prior to infection. 
Overnight cultures of GFP-expressing bacterial strains were diluted 1:10 and grown for 
2 hours until mid-log phase growth (0.8 at OD600). 1 ml of each strain was centrifuged 
at 14,000 RPM for 3 minutes. Supernatants were removed and the pellet was 
resuspended in 1 ml of RPMI. 10 µl of the resuspended bacterial strains were added to 
the macrophages, resulting in an MOI of 50, and incubated at 37°C in 5% CO2 for 30 
minutes. Macrophages were then washed and harvested with 0.02% EDTA in PBS and 
analyzed by flow cytometry to determine the amount of internalized GFP-expressing 
bacteria. Macrophage gating was determined first by forward scatter versus side scatter 
to eliminate dead cells and debris. Secondary gating was determined by GFP 
expression versus red autofluorescence to count the number of macrophages 
containing GFP-expressing bacteria (41, 64, 75, 81).  
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Table 1. Description of bacterial strains 
 
Name Genotype and/or Phenotype Source 
P. aeruginosa   
FRD1 mucA22 Alg+ LPS-O- (61) 
FRD1131 FRD1algD::Tn501-33 Alg- (10) 
FRD1131C’ FRD1131(pAlg2) Cbr Alg+ This study 
FRD1 GFP FRD1(pMF230) Cbr GFP+ This study 
FRD1131 GFP FRD1131(pMF230) Cbr GFP+ This study 
FRD1 Flg- FRD1 flgB::Tn mariner Tcr Flg- Ohman lab strain 
FRD1131 Flg- FRD1131 flgB::Tn mariner Tcr Flg- Ohman lab strain 
FRD1 mC FRD1(pWR01) Cbr mCherry (mC+) This study 
FRD1131 mC FRD1311(pWR01) Cbr mCherry (mC+) This study 
FRD1810 FRD1, LPS-O4+ Ohman lab strain 
PAO1 WT Alg- (32) 
PDO300 PAO1 mucA22 Alg+ (53) 
PAO1 Flg- PAO1 flgB::Tn Tcr Flg- Seattle library 
   
E. coli   
DH5α GFP DH5α(pMF230) Apr GFP+ Ohman lab strain 
DH5α DH5α(pRK2013) Tra+ Kmr Ohman lab strain 
DH5α DH5α(pAlg2) Cbr algD operon Ohman lab strain 
DH5α DH5α(pWR01) Apr mCherry (mC+) This study 
HfrH WT (5) 
HfrH GFP HfrH(pMF230) Apr GFP+ This study 
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Table 2. Description of bacterial plasmids 
 
Name Genotype Source 
pMF230 pMF36 oriT SF Ptrc-GFP Ap
r (59) 
pRK2013 ColE1-Tra(RK2)+ Kmr (15) 
pAlg2 cos oriT Apr Kmr algD operon (10) 
pMF54 oriV, Ptrc, lacI
q, oriT(RK2) bla (60) 
pMP7605 pBBR1MCS-5 mCherry (mC+) Gmr (44) 
pWR01 pMF54 Ptrc-mCherry (mC
+) Cbr This study 
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Gentamicin protection assay 
 2x105 THP-1 or MH-S macrophages were grown in 12-well plates prior to 
infection. Overnight cultures of bacterial strains were diluted 1:10 and grown for 2 hours 
until mid-log phase growth (0.8 OD600). 1 ml of each culture (1 x 109 cells/ml) was 
centrifuged at 14,000 RPM for 3 minutes. Supernatants were removed and the pellet 
was resuspended in 1 ml of RPMI. Macrophages were infected with 10 µl of the 
resuspended bacterial strains (1 x 107 cells), resulting in a MOI of 50, and incubated at 
37°C in 5% CO2 for 1 hour. MH-S cells were washed with cold PBS, treated with 
gentamicin (2 mg/ml) for 30 minutes to kill extracellular bacteria, washed twice with cold 
PBS, and subsequently lysed with 0.25% SDS to release intracellular bacteria. Cell 
lysates were serially diluted 1:10 and 100 µl of the dilutions were spread on LB agar 
plates. Plates were incubated at 37°C overnight and colonies were counted to 
determine CFU. For some experiments, blocking antibodies were added 15 minutes 
prior to infection and signaling inhibitors were added 30 minutes prior to infection, and 
both remained present during phagocytosis. Controls including wells containing only 
bacteria were treated with gentamicin (2 mg/ml) for 30 minutes or 0.25% SDS which 
resulted in 0% or 100% CFU, respectively, compared to untreated wells (14, 17, 55). 
 
Intracellular survival assay 
 2x105 THP-1 macrophages were grown in 12-well plates prior to infection. 
Overnight cultures of bacterial strains were diluted 1:10 and grown for 2 hours until mid-
log phase growth (0.8 OD600). 1 ml of each strain was centrifuged at 14,000 RPM for 3 
minutes. Supernatants were removed and the pellet was resuspended in 1 ml of RPMI. 
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Macrophages were infected with 10 µl of the resuspended bacterial strains, resulting in 
a MOI of 50, and incubated at 37°C in 5% CO2 for 2 hours. Macrophages were washed 
with cold PBS and treated with gentamicin (2 mg/ml) for 30 minutes. Following 
gentamicin treatment (Time 0) macrophages were incubated at 37°C in 5% CO2 for 2 
hours. At varying time points throughout the 2 hour incubation, macrophages were 
washed twice with cold PBS and lysed with 0.25% SDS to release intracellular bacteria. 
Cell lysates were serially diluted 1:10 and 100 µl of the dilutions was spread on LB agar 
plates. Plates were incubated at 37°C overnight and colony counts were performed 
(55). 
 
Microscopy 
 THP-1 or MH-S macrophages were grown in chamber slides or glass bottom 
dishes prior to infection. Overnight cultures of bacterial strains were diluted 1:10 and 
grown for 2 hours until mid-log phase growth (0.8 OD600). 1 ml of each strain was 
centrifuged at 14,000 RPM for 3 minutes. Supernatants were removed and the pellet 
was resuspended in 1 ml of RPMI. For fluorescent microscopy, bacterial strains 
expressing GFP were added at a MOI of 500 for 2 hours and visualized with a Zeiss 
Axiovert 200 using a green filter. For confocal microscopy, MH-S macrophages were 
labeled using Alexa488-Cholera Toxin B (Molecular Probes) to label ganglioside GM1 in 
the membranes for 15 minutes prior to the addition of mCherry-expressing bacteria. 
Macrophages were washed and fixed with 4% formaldehyde for 15 minutes. 
Formaldehyde was removed and macrophages were washed once with PBS. 
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Macrophages and associated bacteria were visualized using a Zeiss LSM 710 confocal 
microscope at 63x magnification (33, 37). 
 
Swimming motility assay 
 Overnight cultures of bacterial strains were diluted 1:10 and grown for 2 hours 
until mid-log phase growth (0.8 OD600). 0.5% LB agar plates were point inoculated with 
1 µl of the mid-log phase bacterial culture and incubated at 37°C overnight. 24 hours 
later, the diameter of the resulting growth was measured (21, 48). 
 
Alginate isolation and purification 
 Strain FRD1 was grown overnight in 10 ml of LB liquid media at 37°C with 
shaking, and 1 ml was used to inoculate 100 ml of fresh LB, which was incubated 
overnight at 37°C with shaking. The culture was then centrifuged at 10,000 rpm for 60 
minutes. Supernatants were moved to a sterile beaker where 2 volumes of cold ethanol 
were added and mixed. The precipitate was removed with a sterile glass plate spreader 
and placed into a petri dish and dried at 37°C. The precipitate was dissolved in 100 ml 
of 1 M NaCl overnight at 5°C with agitation. 100 ml of cold isopropanol was added and 
the solution was centrifuged at 10,000 RPM and 5°C for 60 minutes to collect the 
precipitate. The resulting precipitate was removed with a sterile glass plate spreader 
and dissolved in 20 ml saline, overnight at 37°C with shaking. Once dissolved, trypsin 
(0.5 mg/ml) was added to eliminate contaminating proteins, and incubation continued 
for 2 hours at 37°C with shaking. 1 g of NaCl was added followed by 1 volume of cold 
isopropanol. The solution was centrifuged at 10,000 RPM and 5°C for 60 minutes. The 
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resulting precipitate was dissolved in 20 ml saline. The solution was dialyzed against 
distilled water (19). 
 
Alginate concentration 
 A borate stock was prepared by dissolving 2.474 g of H3BO3 in 4.5 ml of 4 M 
KOH and diluting to 10 ml with distilled water. A sulfuric acid-borate reagent was 
prepared by diluting 500 µl of borate stock up to 20 ml with H2SO4. A carbazole stock 
was prepared by adding 10 mg of carbazole to 10 ml ethanol. An alginate stock solution 
was prepared by adding 20 mg of sodium alginate (Sigma) to 10 ml saline. 
 1 ml of the sulfuric acid-borate reagent was added to a glass tube on ice. 100 µl 
of an alginate sample solution or control was layered on top of the sulfuric acid-borate 
reagent and the tube was vortexed and placed on ice for 3 minutes. 33 µl of carbazole 
reagent was added and the tube was vortexed and placed on ice for 3 minutes. The 
tubes were incubated in a 55°C water bath for 30 minutes. Following incubation, 
samples were removed and analyzed by spectrophotometry. Absorbance was 
measured at 530 nm. A standard curve was generated using the alginate stock solution 
and was assayed in duplicate. Standard curve data was graphed and alginate 
concentration was calculated by determining the equation of the resulting trend line 
(40). 
 
Western blot analysis 
2x106 MH-S macrophages were grown in 6-well plates prior to infection. Overnight 
cultures of bacterial strains were diluted 1:10 and grown for 2 hours until mid-log phase 
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growth (0.8 OD600). 1 ml of each strain was centrifuged at 14,000 RPM for 3 minutes. 
Supernatants were removed and the pellet was resuspended in 1 ml of RPMI. 
Macrophages were starved in serum-free RPMI for 6 hours and subsequently infected 
with 100 µl of the resuspended bacterial strains, resulting in a MOI of 50, and incubated 
at 37°C in 5% CO2 for various time points. After infection, macrophages were washed 
twice with cold PBS and lysed with 70 µl RIPA (Cell Signal) containing 1 mM PMSF. 
Samples were centrifuged at 14,000 x g for 10 minutes and supernatants were frozen at 
-80°C for storage prior to analysis. Protein concentration was determined using a 
Bradford protein assay, and 20 µg of protein was separated on a 12% polyacrylamide 
gel in Tris-glycine electro-blotting buffer (National Diagnostics ec-870) for 90 minutes at 
150 V. Proteins were transferred to PVDF with a semi-dry transfer cell (Bio-Rad) in Tris-
glycine-SDS buffer (National diagnostics ec-880) at 25 V for 30 minutes. The blot was 
blocked with 2% BSA in TBS/Tween (0.05%, Amresco K873) for 1 hour. Primary 
antibodies to various macrophage proteins (Cell Signal, 4060, 4691, 4370, 4695) were 
used at 1:1000 in TBS/Tween with 2% BSA overnight, at 4°C with shaking. The blot was 
washed 3 times, for 10 minutes each, with TBS/Tween and secondary antibodies were 
added. α-Rabbit IgG-peroxidase secondary antibody (Sigma A9169) was used at 
1:5000 in TBS/Tween with 2% BSA for 45 minutes at room temperature with shaking. 
The blot was washed 4 times, for 10 minutes each, with TBS/Tween. West Pico 
chemiluminescence substrate (Thermo Sci 34080) was added for 5 minutes prior to film 
exposure. To strip the blot to allow for additional probes, stripping buffer (Thermo Sci 
21059) was added for 15 minutes at room temperature with shaking. The blot was 
washed with TBS/Tween and blocked with 2% BSA for 1 hour. 
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Acid sphingomyelinase activity 
 2x106 MH-S macrophages were grown in 6-well plates prior to infection. 
Overnight cultures of bacterial strains were diluted 1:10 and grown for 2 hours until mid-
log phase growth (0.8 OD600). 1 ml of each strain was centrifuged at 14,000 RPM for 3 
minutes. Supernatants were removed and the pellet was resuspended in 1 ml of RPMI. 
Macrophages were serum starved for 6 hours prior to infection. 100 µl of the 
resuspended bacterial strains were added, resulting in a MOI of 50, and incubated at 
37°C in 5% CO2 for 15 minutes. The macrophages were washed twice with cold PBS 
and scraped using water with 1mM PMSF. Cells were harvested and lysed by three 
freeze-thaw cycles in liquid nitrogen. Samples were spun at 14,000 x g for 10 minutes to 
remove cell membranes and debris, and supernatants were frozen at -80°C for storage 
prior to analysis. Protein concentration was determined using a Bradford protein assay 
and ASMase activity in 2 µg of protein was measured using an ASMase activity assay 
kit (Echelon K-3200). 
 
IL-8 and MIP-2 ELISA 
 2x105 THP-1 or MH-S macrophages were grown in 12-well plates prior to 
infection. Overnight cultures of bacterial strains were diluted 1:10 and grown for 2 hours 
until mid-log phase growth (0.8 OD600). 1 ml of each strain was centrifuged at 14,000 
RPM for 3 minutes. Supernatants were removed and the pellet was resuspended in 1 
ml of RPMI. MH-S and THP-1 cells were infected with 10 µl of the resuspended 
bacterial strains, resulting in a MOI of 50, and incubated at 37°C in 5% CO2 for 8 hours. 
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Supernatants were collected and centrifuged to remove any remaining bacteria. IL-8 or 
MIP-2 levels were determined by ELISA Quantikine kit (R&D Systems d8000c, mm200). 
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Chapter 3 
Alginate Production by Pseudomonas aeruginosa Inhibits Opsonic 
and non-Opsonic Phagocytosis by Human and Murine Macrophages 
 
 
 
Mucoid Pseudomonas aeruginosa inhibits phagocytosis by human macrophages 
 Previous studies indicated that mucoid Pseudomonas aeruginosa are protected 
from non-opsonic phagocytosis (8, 43, 68). However, these findings came from visual 
observations and were not compared to proper controls. The effect of alginate 
production on non-opsonic phagocytosis of planktonic P. aeruginosa by macrophages 
has not been quantitatively studied and may contribute to the survival of P. aeruginosa 
within the CF lung. To understand the effect of alginate on phagocytosis of P. 
aeruginosa, I first wanted to establish a time course for phagocytosis using the human 
monocytic cell line, THP-1. P. aeruginosa strain FRD1, an alginate producing (Alg+) CF 
isolate, and its isogenic algD::Tn501-33 (Alg-) mutant were compared. GFP-expressing 
FRD1 and FRD1131 were incubated with THP-1 macrophages and were analyzed by 
flow cytometry at various time points up to 4 hours (Figure 1). At the earliest time point, 
phagocytosis of FRD1131 exceeded that of FRD1 by 25%. This trend continued out to 4 
hours despite increased phagocytosis of both strains. 
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Figure 1. Time course of phagocytosis of FRD1 and FRD1131 by THP-1 
macrophages. THP-1 macrophages were infected with GFP-expressing FRD1 (Alg+) or 
FRD1131 (Alg-) at a MOI of 500 for various time points up to 4 hours. Percent 
phagocytosis indicates the percent of macrophages that are associated with GFP-
expressing P. aeruginosa as detected by flow cytometry. Data are shown as mean and 
standard deviation of two samples. 
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 GFP-expression was detectable by flow cytometry, and I wanted to determine if 
there was enough GFP-expression to observe phagocytosis by fluorescent microscopy. 
After establishing that phagocytosis could be observed as early as 30 minutes post 
infection, I visualized the difference at that time point. GFP-expressing FRD1 and 
FRD1131 were added to THP-1 macrophages and visualized using fluorescent 
microscopy (Figure 2). An overlay of the fluorescent P. aeruginosa on a light image of 
the macrophages revealed many more Alg- FRD1131 within, and associated with, the 
macrophages compared to the Alg+ FRD1. 
 
Alginate+ Pseudomonas aeruginosa reduce the proportion of human 
macrophages that phagocytize and the total amount of bacteria phagocytized 
 Using the time point at which phagocytosis was maximal, flow cytometry was 
repeated to determine if alginate production significantly affects phagocytosis. After a 30 
minute incubation, alginate production by FRD1 significantly reduced the amount of 
phagocytosis by THP-1 macrophages (Figure 3). This indicates that alginate production 
is protective under non-opsonic conditions. 
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Figure 2. Visualization of THP-1 macrophages following phagocytosis of GFP-
expressing FRD1 and FRD1131. Images show GFP-expressing P. aeruginosa 
overlayed on a light image of THP-1 macrophages. THP-1 macrophages were infected 
with GFP-expressing FRD1 (Alg+) or FRD1131 (Alg-) for 30 minutes and visualized by 
fluorescent microscopy. Reduced phagocytosis and association with macrophages are 
observed with the FRD1 compared to the FRD1131 strain. 
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Figure 3. Percentage of THP-1 macrophages that have phagocytized FRD1 and 
FRD1131 at 30 minutes. THP-1 macrophages were infected with GFP-expressing 
FRD1 (Alg+) or FRD1131 (Alg-) for 30 minutes. Percent phagocytosis indicates the 
percent of macrophages that are associated with GFP-expressing P. aeruginosa as 
detected by flow cytometry. Phagocytosis of FRD1 was significantly inhibited compared 
to FRD1131. Data are shown as mean and standard deviation of three samples. 
Statistical significance is determined by Students t-Test (*; P < 0.05, **; P < 0.01, ***; P 
< 0.001). 
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 It is possible for some bacteria to remain on the outside of the macrophages 
despite washing prior to flow cytometric analysis. Therefore, too ensure that the 
observed difference in phagocytosis was indeed due to internalized bacteria, an 
alternative phagocytosis assay was used. In this assay, FRD1 or FRD1131 were 
incubated with THP-1 macrophages for 1 hour and macrophages were subsequently 
washed and treated with gentamicin to kill extracellular bacteria. After lysing the 
macrophages and plating the lysate, colony counts were performed. It is important to 
note that this assay measures the number of bacteria phagocytosed, whereas the flow 
cytometric assay measures the number of macrophages that have phagocytized 
bacteria. As in the previous assay, alginate production by FRD1 significantly inhibited 
phagocytosis by THP-1 macrophages (Figure 4). To ensure that the inhibition of 
phagocytosis was due to the production of alginate alone, I complemented algD in 
FRD1131 (FRD1131C’) to restore alginate production. Alginate production by 
FRD1131C’, as with FRD1, was able to significantly inhibit non-opsonic phagocytosis, 
suggesting that alginate alone was responsible for the inhibition of phagocytosis that 
was observed. Together these data indicated that alginate production by P. aeruginosa 
significantly reduced the proportion of macrophages that phagocytosed P. aeruginosa, 
as well as the total number of bacteria phagocytized by the macrophages. 
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Figure 4. Number of bacteria phagocytized by THP-1 macrophages after 1 hour. 
THP-1 macrophages were infected with FRD1 (Alg+), FRD1131 (Alg-), FRD1131C’ 
(Alg+), or HfrH (positive control) for 1 hour. CFU indicates the number of colony-forming 
units recovered from macrophages. Phagocytosis of FRD1 and FRD1131C’ was 
significantly inhibited compared to FRD1131. Data are shown as mean and standard 
deviation of a representative triplicate experiment. Statistical significance is determined 
by Students t-Test (*; P < 0.05, **; P < 0.01, ***; P < 0.001). 
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Intracellular survival of Pseudomonas aeruginosa is unaffected by alginate 
production 
 It is possible that alginate enhances survival of P. aeruginosa by altering 
intracellular survival after phagocytosis. To determine the amount of intracellular 
survival, a modified phagocytosis assay was used. THP-1 macrophages were cultured 
with FRD1 or FRD1131 for 2 hours. Instead of lysing the macrophages immediately 
after gentamicin treatment, macrophages were cultured for up to two additional hours 
and lysed at 30 minute intervals. This allowed me to determine the number of P. 
aeruginosa that have survived within the macrophages over 2 hours (Figure 5). Survival 
rates between the two strains remained similar at each time point throughout the 2 hour 
period. Thus, alginate production by FRD1 did not appear to enhance intracellular 
survival within macrophages. 
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Figure 5. Time course of intracellular survival of FRD1 and FRD1131 within THP-1 
macrophages. THP-1 macrophages were infected with FRD1 (Alg+) or FRD1131 (Alg-) 
for 2 hours and incubated for additional time following gentamicin treatment. Percent 
survival indicates the number of colony-forming units recovered from macrophages at 
the indicated time point relative to time 0. Survival of FRD1 was similar to that of 
FRD1131 at each time point. Data are shown as mean and standard deviation of two 
separate experiments. 
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Alginate+ Pseudomonas aeruginosa reduce the proportion of murine alveolar 
macrophages that phagocytize and the total amount of bacteria phagocytized 
 In cystic fibrosis, P. aeruginosa will encounter alveolar macrophages within the 
lung. Alveolar macrophages differ from peripheral macrophages in several important 
ways including different receptor expression, altered activation, and survival (25, 56). 
Therefore, it was important to determine if alginate production also affected 
phagocytosis by alveolar macrophages. To investigate this, the murine alveolar 
macrophage cell line MH-S was used. As with THP-1, I first wanted to establish a time 
line for phagocytosis. Again, substantial phagocytosis was observed as early as 30 
minutes post infection and continued out to 1 hour (Figure 6). There was also an 
observable difference in the phagocytosis of FRD1 (Alg+) compared to FRD1131 (Alg-). 
 To confirm that alginate production significantly inhibited phagocytosis by MH-S 
macrophages, flow cytometry was used. MH-S macrophages were incubated with FRD1 
or FRD1131 for 30 minutes. Similarly to THP-1 macrophages, alginate production by P. 
aeruginosa significantly inhibited non-opsonic phagocytosis by MH-S (Figure 7). 
 The gentamicin uptake assay was also repeated using MH-S macrophages to 
confirm the inhibition observed in the flow cytometric assay. FRD1, FRD1131, or 
FRD1131C’ were added to MH-S macrophages for 1 hour. Colony counts revealed the 
significant inhibitory effect of alginate production by FRD1 on phagocytosis (Figure 8). 
Additionally, the Alg+ complemented strain, FRD1131C’, was also phagocytized 
significantly less than Alg- FRD1131, suggesting that alginate production alone is 
responsible for the inhibition of phagocytosis that is observed. 
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Figure 6. Time course of phagocytosis of FRD1 and FRD1131 by MH-S 
macrophages. MH-S macrophages were infected with GFP-expressing FRD1 (Alg+) or 
FRD1131 (Alg-) for various time points up to 1 hour. Percent phagocytosis indicates the 
percent of macrophages that are associated with GFP-expressing P. aeruginosa as 
detected by flow cytometry. Reduced phagocytosis of FRD1 compared to FRD1131 is 
observed as early as 30 minutes. 
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Figure 7. Percentage of MH-S macrophages that have phagocytized bacteria at 30 
minutes. MH-S macrophages were infected with GFP-expressing FRD1 (Alg+), 
FRD1131 (Alg-), or HfrH for 30 minutes. Percent phagocytosis indicates the percent of 
macrophages that are associated with GFP-expressing bacteria as detected by flow 
cytometry. Phagocytosis of FRD1 was significantly inhibited compared to FRD1131. 
Data are shown as mean and standard deviation of three separate experiments. 
Statistical significance is determined by Students t-Test (*; P < 0.05, **; P < 0.01, ***; P 
< 0.001). 
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Figure 8. Number of bacteria phagocytized by MH-S macrophages after 1 hour. 
MH-S macrophages were infected with FRD1 (Alg+), FRD1131 (Alg-), FRD1131C’ (Alg+), 
or HfrH for 1 hour. CFU indicates the number of colony-forming units recovered from 
macrophages. Phagocytosis of FRD1 and FRD1131C’ was significantly inhibited 
compared to FRD1131. Data are shown as mean and standard deviation of three 
separate experiments. Statistical significance is determined by Students t-Test (*; P < 
0.05, **; P < 0.01, ***; P < 0.001). 
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Alginate+ Pseudomonas aeruginosa inhibit opsonic phagocytosis by human and 
murine macrophages 
 Previous studies investigated the role of alginate structure in protecting 
planktonic P. aeruginosa, as well as P. aeruginosa in a biofilm, from opsonic killing (43, 
46, 63). However, because these studies only addressed bacterial survival rather than 
phagocytosis directly, I wanted to repeat them with our macrophage cell lines. First it 
was necessary to determine the optimal concentration of human serum necessary for 
opsonic phagocytosis. MH-S macrophages were incubated with FRD1 and FRD1131 for 
30 minutes with increasing concentrations of human serum (Figure 9). At all 
concentrations of serum tested, phagocytosis of Alg+ FRD1 appeared much lower than 
Alg- FRD1131, suggesting that alginate inhibits opsonic phagocytosis. 0.5% human 
serum was chosen for further experiments as this was the lowest concentration that 
enhanced phagocytosis. 
 To determine if alginate significantly inhibited opsonic phagocytosis, previous 
assays were repeated using the established concentration of 0.5% human serum. THP-
1 macrophages were incubated for 1 hour with various bacterial strains in the presence 
of human serum. After treatment with gentamicin, colony counts were performed to 
determine the amount of phagocytosis (Figure 10). Both Alg+ FRD1 and the Alg+ 
complementation strain, FRD1131C’, were phagocytized significantly less than Alg- 
FRD1131. 
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Figure 9. Time course showing the percentage of MH-S macrophages that have 
phagocytized FRD1 or FRD1131 with increasing concentrations of human serum. 
MH-S macrophages were infected with GFP-expressing FRD1 (Alg+) or FRD1131 (Alg-) 
for 30 minutes in the presence of increasing concentrations of human serum. Percent 
phagocytosis indicates the percent of macrophages that are associated with GFP-
expressing P. aeruginosa as detected by flow cytometry. An increase in the 
phagocytosis of FRD1 compared to FRD1131 is observed beginning at 0.5% human 
serum. 
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Figure 10. Number of bacteria phagocytized by THP-1 macrophages after 1 hour 
in the presence of 0.5% human serum. THP-1 macrophages were infected with 
FRD1, FRD1131, FRD1131C’, or HfrH for 1 hour in the presence of 0.5% human serum. 
CFU indicates the number of colony-forming units recovered from macrophages. 
Opsonic phagocytosis of FRD1 and FRD1131C’ were significantly inhibited compared to 
FRD1131. Data are shown as mean and standard deviation of a representative triplicate 
experiment. Statistical significance is determined by Students t-Test (*; P < 0.05, **; P < 
0.01, ***; P < 0.001). 
  
 50 
 
 Inhibition of opsonic phagocytosis was assessed in MH-S macrophages as well. 
MH-S macrophages were cultured with GFP-expressing FRD1, FRD1131, or HfrH in the 
presence of 0.5% human serum for 30 minutes and analyzed by flow cytometry (Figure 
11). Similarly to THP-1, opsonic phagocytosis of FRD1 was significantly less than that 
of FRD1131. 
 
The inhibitory effect of alginate on phagocytosis by murine macrophages is not 
limited to the FRD strain 
 As an additional control for strain specific effects to ensure that alginate is 
responsible for the inhibitory effect on phagocytosis, another P. aeruginosa strain was 
utilized. PAO1 is a clinical wound isolate routinely used in many labs. PDO300 is a 
mutant strain of PAO1 with a mucA22 mutation, similar to FRD1, causing constitutive 
alginate production. MH-S macrophages were cultured with FRD1, PAO1, or PDO300 
for 1 hour. After treatment with gentamicin, colony counts were performed to determine 
the amount of phagocytosis (Figure 12). As with FRD1, Alg+ PDO300 was phagocytized 
significantly less than Alg- PAO1. Therefore, the inhibitory effect of alginate production 
on phagocytosis is not limited to the FRD strain. 
 Taken together, this data is the first to demonstrate that alginate production by P. 
aeruginosa has the potential to significantly inhibit phagocytosis by both human and 
murine macrophages, in opsonic and non-opsonic conditions. 
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Figure 11. Percentage of MH-S macrophages that have phagocytized bacteria 
after 30 minutes in the presence of 0.5% human serum. MH-S macrophages were 
infected with GFP-expressing FRD, FRD1131, or HfrH for 30 minutes in the presence of 
0.5% human serum. Percent phagocytosis indicates the percent of macrophages that 
are associated with GFP-expressing bacteria as detected by flow cytometry. Opsonic 
phagocytosis of FRD1 was significantly inhibited compared to FRD1131. Data are 
shown as mean and standard deviation of three separate experiments. Statistical 
significance is determined by Students t-Test (*; P < 0.05, **; P < 0.01, ***; P < 0.001). 
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Figure 12. Number of PAO1 or PDO300 phagocytized by MH-S macrophages after 
1 hour. MH-S macrophages were infected with FRD1 (Alg+), PAO1 (Alg-), or PDO300 
(Alg+) for 1 hour. CFU indicates the number of colony-forming units recovered from 
macrophages. Phagocytosis of PDO300 was significantly inhibited compared to PAO1. 
Data are shown as mean and standard deviation of a representative triplicate 
experiment. Statistical significance is determined by Students t-Test (*; P < 0.05, **; P < 
0.01, ***; P < 0.001). 
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Chapter 4 
Additional Mediators of Phagocytosis of Pseudomonas aeruginosa 
 
 
 
The role of LPS on the phagocytosis of Pseudomonas aeruginosa 
 Figure 12 indicates that while alginate production by the PAO strain significantly 
decreased phagocytosis, it did not reduce it to the level of FRD1. Therefore there must 
be an additional factor, or factors, inhibiting phagocytosis. Like many CF-adapted 
strains, FRD1 has a mutation that blocks the production of O-side chains on LPS, which 
are present in PAO. To explore the role of differing LPS structures in the phagocytosis 
of P. aeruginosa, strain FRD1810 was compared to FRD1. FRD1810 is a FRD1 
recombinant in which LPS O-side chain production has been restored. MH-S 
macrophages were cultured with Alg+ FRD1 or Alg+ FRD1810 for 1 hour. After treatment 
with gentamicin, colony counts were performed to determine the amount of 
phagocytosis (Figure 13). Restored O-side chain production resulted in the 
phagocytosis of significantly more FRD1810 than FRD1. This indicated that LPS was 
able to have some effect on phagocytosis in the presence of alginate. 
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Figure 13. Number of FRD1 or FRD1810 phagocytized by MH-S macrophages after 
1 hour. MH-S macrophages were infected with FRD1 (Alg+) or FRD1810 (Alg+) for 1 
hour. CFU indicates the number of colony-forming units recovered from macrophages. 
Phagocytosis of FRD1810 was significantly increased compared to FRD1. Data are 
shown as mean and standard deviation of a representative triplicate experiment. 
Statistical significance is determined by Students t-Test (*; P < 0.05, **; P < 0.01, ***; P 
< 0.001). 
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The role of motility and flagellum on the phagocytosis of Pseudomonas 
aeruginosa 
 It has been reported that both flagellum and motility are critical for promoting the 
phagocytosis of P. aeruginosa (1, 47, 50, 51). To ensure that the inhibitory effects of 
alginate production on phagocytosis are not due to changes in motility, a motility assay 
was used. Soft agar plates, which allow for the movement of motile bacteria, were used 
to measure motility. Each plate was inoculated with a log phase culture of FRD1, 
FRD1131, FRD1131C’, PAO1, or HfrH and, after incubation, the diameter of the 
resulting growth was measured (Figure 14). All FRD strains tested had similar, minimal 
growth compared to the motile E. coli strain HfrH, indicating non-motility for all strains. 
Non-motility of these FRD strains was also visually confirmed by microscopy. 
 It is possible that flagellum is expressed by P. aeruginosa despite being non-
motile and this expression could enhance phagocytosis. To address this, flagellum 
mutants were constructed for FRD1, FRD1131, and PAO1 and phagocytosis 
experiments were repeated using these strains (Figure 15). PAO1flg- was phagocytized 
significantly less than PAO1. Likewise, FRD1flg- was phagocytized significantly less 
than FRD1, suggesting the presence of flagellum on FRD1. Surprisingly, phagocytosis 
of FRD1131flg- was significantly increased relative to FRD1131. This is possibly due to 
the one or more stimulatory genes being introduced in the process of disabling flagellum 
expression. Conversely, it is possible that an inhibitory gene was disrupted in the 
process. The presence of flagellum does appear to affect the phagocytosis of P. 
aeruginosa, however, the contribution of flagellum to the phagocytosis of FRD1131 is 
not yet known.  
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Figure 14. Growth diameter of bacteria in 0.5% agar plates. 0.5% agar plates were 
inoculated with FRD1, FRD1131, FRD1131C’, PAO1, or HfrH and incubated at 37°C 
overnight. The diameter of the resulting growth was measured. FRD1, FRD1131, and 
FRD1131C’ demonstrated a significant lack of motility relative to the motile PAO1 and 
HfrH. Data are shown as mean and standard deviation of three separate experiments. 
Statistical significance is determined by Students t-Test (*; P < 0.05, **; P < 0.01, ***; P 
< 0.001). 
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Figure 15. Number of bacteria with and without flagellum phagocytized by MH-S 
macrophages. MH-S macrophages were infected with FRD1, FRD1131, PAO1, and 
corresponding Flg- mutants for 1 hour. CFU indicates the number of colony-forming 
units recovered from macrophages. Phagocytosis of FRD1 and PAO1 Flg- mutants was 
significantly decreased. Phagocytosis of FRD1131 Flg- was significantly increased 
compared to FRD1131. Data are shown as mean and standard deviation of a 
representative triplicate experiment. Statistical significance is determined by Students t-
Test (*; P < 0.05, **; P < 0.01, ***; P < 0.001). 
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Chapter 5 
Local Alginate Production is Required to Inhibit Phagocytosis 
 
 
 
Exogenous alginate is unable to inhibit phagocytosis of non-mucoid 
Pseudomonas aeruginosa by murine macrophages 
 To begin to understand the role of alginate in the inhibition of phagocytosis I next 
determined if the addition of exogenous alginate would protect FRD1131 from 
phagocytosis. Previous publications have suggested that exogenous alginate may 
protect planktonic and biofilm P. aeruginosa (46, 68). Alginate was isolated from FRD1 
and its concentration determined. MH-S macrophages were cultured with FRD1131 in 
the presence of increasing concentrations of FRD1 alginate (Figure 16). The addition of 
FRD1 alginate did not protect FRD1131 from phagocytosis. It is unlikely that alginate is 
inducing an inhibitory signal within the macrophages; as such an effect would still be 
possible from exogenous alginate. Instead, it is possible that alginate is preventing an 
interaction between the macrophage and P. aeruginosa. Surprisingly, the addition of 
200 µg/ml of FRD1 alginate significantly increased phagocytosis of FRD1131. This is 
likely due to LPS contamination of the alginate during the isolation procedure. 
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Figure 16. Percentage of MH-S macrophages that have phagocytized FRD1131 
after 30 minutes in the presence of FRD1 alginate. MH-S macrophages were 
infected with GFP-expressing FRD1 or FRD1131 for 30 minutes with increasing 
concentrations of FRD1 alginate. Percent phagocytosis indicates the percent of 
macrophages that are associated with GFP-expressing bacteria as detected by flow 
cytometry. Phagocytosis of FRD1131 (Alg-) was not significantly inhibited with the 
addition of FRD1 alginate. Data are shown as mean and standard deviation of three 
separate experiments. Statistical significance is determined by Students t-Test (*; P < 
0.05, **; P < 0.01, ***; P < 0.001). 
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 To determine if LPS contamination could be responsible for the enhanced 
phagocytosis seen in Figure 16, the experiment was repeated using seaweed alginate. 
Although seaweed alginate is free from LPS contamination, it is not acetylated like 
FRD1 alginate. Again, an increasing concentration of alginate was added with FRD1131 
to MH-S macrophages (Figure 17). As with FRD1 alginate, seaweed alginate was 
unable to protect FRD1131 from phagocytosis. The enhanced phagocytosis observed 
when using FRD1 alginate was eliminated with the use of seaweed alginate suggesting 
that LPS contamination was likely the cause of the additional stimulation. 
 
Mucoid Pseudomonas aeruginosa is unable to protect non-mucoid Pseudomonas 
aeruginosa from phagocytosis by murine macrophages 
 Since exogenous alginate was unable to protect P. aeruginosa from 
phagocytosis, my hypothesis was that the alginate produced by FRD1 would not protect 
FRD1131 from phagocytosis. FRD1 and FRD1131 were added either individually or 
together to MH-S macrophages for 1 hour. After treatment with gentamicin, colony 
counts were performed to determine the amount of phagocytosis (Figure 18). FRD1 and 
FRD1131 have visually distinct colony morphologies allowing for each strain to be 
distinguished from the other when a mixed culture was used. When both strains were 
added to macrophages together there was no significant difference between the amount 
of phagocytosis of FRD1131, when mixed with FRD1, compared to FRD1131 alone. 
Alginate production by FRD1 was unable to inhibit the phagocytosis of FRD1131 
suggesting that alginate only benefits the individual bacteria that produced it. Likewise, 
FRD1 was phagocytized equally regardless of the presence of FRD1131. 
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Figure 17. Percentage of MH-S macrophages that have phagocytized FRD1131 
after 30 minutes in the presence of seaweed alginate. MH-S macrophages were 
infected with GFP-expressing FRD1131 for 30 minutes with increasing concentrations of 
seaweed alginate. Percent phagocytosis indicates the percent of macrophages that are 
associated with GFP-expressing bacteria as detected by flow cytometry. Phagocytosis 
of FRD1131 (Alg-) was not significantly inhibited with the addition of seaweed alginate. 
Data are shown as mean and standard deviation of three samples. Statistical 
significance is determined by Students t-Test (*; P < 0.05, **; P < 0.01, ***; P < 0.001). 
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Figure 18. Number of FRD1 or FRD1131 phagocytized by MH-S macrophages after 
1 hour when infected separately or together. MH-S macrophages were infected with 
FRD1 (Alg+), FRD1131 (Alg-), or both strains combined for 1 hour. CFU indicates the 
number of colony-forming units recovered from macrophages. Phagocytosis of 
FRD1131 was not significantly inhibited by the addition of FRD1. Data are shown as 
mean and standard deviation of three separate experiments. Statistical significance is 
determined by Students t-Test (*; P < 0.05, **; P < 0.01, ***; P < 0.001). 
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Chapter 6 
Alginate Confers Protection to Pseudomonas aeruginosa by Blocking 
Important Phagocytosis Receptors and Inhibiting Binding 
 
 
 
Alginate inhibits phagocytosis of Pseudomonas aeruginosa by murine 
macrophages by reducing binding 
 The first step in phagocytosis is the binding of bacterial ligands to receptors on 
the macrophage surface. Since exogenous alginate and alginate produced in a mixed 
culture were unable to inhibit phagocytosis this suggests that alginate must be present 
on the surface of P. aeruginosa to inhibit phagocytosis. It is possible that alginate on the 
bacterial surface could interfere with binding to the macrophage. To assess binding, 
cytochalasin D was used to inhibit actin polymerization and therefore prevent 
phagocytosis. Various strains were added to MH-S macrophages in the presence of 
cytochalasin D for 1 hour. After incubation, macrophages were washed to remove 
unbound bacteria and lysed to free any bound bacteria (Figure 19). Alg+ strains FRD1 
and FRD1131C’ were bound significantly less than the non-mucoid FRD1131, 
suggesting that alginate production does significantly inhibit binding to macrophages.  
 Taken together, these results show that alginate inhibits phagocytosis by locally 
reducing binding to the macrophage. Alginate only protects the bacterium that produced 
it and the inhibition of phagocytosis is not due to the presence of alginate in the media. 
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Figure 19. Number of bacteria bound to MH-S macrophages after 1 hour in the 
presence of cytochalasin D. MH-S macrophages were infected with FRD1 (Alg+), 
FRD1131 (Alg-), or FRD1131C’ (Alg+) for 1 hour in the presence of cytochalasin D to 
inhibit phagocytosis. CFU indicates the number of colony-forming units recovered from 
macrophages. Binding of FRD1 and FRD1131C’ was significantly inhibited compared to 
FRD1131. Data are shown as mean and standard deviation of a representative triplicate 
experiment. Statistical significance is determined by Students t-Test (*; P < 0.05, **; P < 
0.01, ***; P < 0.001). 
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Mucoid Pseudomonas aeruginosa induces lipid raft formation in murine 
macrophages 
 Lipid raft formation is important for the phagocytosis of P. aeruginosa, and it is 
possible that alginate inhibits lipid raft formation (37). To assess lipid raft formation, MH-
S macrophages were serum starved for 6 hours and stained with Alexa488-cholera 
toxin B to visualize lipid rafts within the macrophage membrane. Cholera toxin B is an 
effective stain because it binds to ganglioside GM1 within lipid rafts (23). Macrophages 
were then cultured with mCherry-expressing P. aeruginosa for 30 minutes and 
visualized by confocal microscopy (Figure 20). Compared to the uninfected control, both 
FRD1 and FRD1131 induced lipid raft formation in the macrophages. However, 
FRD1131 (Alg-) showed qualitatively more lipid raft staining. A decrease in lipid raft 
formation may contribute to the reduced binding demonstrated in Figure 19. 
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Figure 20. Confocal images showing rested MH-S macrophages labeled with 
cholera toxin interacting with FRD1 or FRD1131. Serum starved MH-S macrophages 
were stained with Alexa488 labeled cholera toxin B (green) which binds to ganglioside 
GM1, to label lipid rafts. Macrophages were infected with mCherry-expressing FRD1 or 
FRD1131 (red) for 30 minutes. Compared to uninfected, resting macrophages both 
FRD1 (Alg+) and FRD1131 (Alg-) were able to induce lipid raft formation. However, the 
Alg- strain showed qualitatively more lipid raft staining. 
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CD11b and CD14 are important in the phagocytosis of Pseudomonas aeruginosa 
by murine macrophages and their binding is likely blocked by alginate 
 My previous studies indicated that alginate production decreased binding of P. 
aeruginosa to murine macrophages with a trend towards reduced lipid raft formation. 
This is possibly due to blocking specific receptor(s) critical to phagocytosis. The cell 
surface receptors CD11b (CR3) and CD14 have both been shown to be important for 
the phagocytosis of P. aeruginosa by macrophages and dendritic cells (29). To address 
the hypothesis that alginate interferes with receptor activation, I investigated how 
alginate affects interaction between P. aeruginosa and CD14 and CD11b. To determine 
if CD11b and CD14 are critical to the phagocytosis of mucoid and non-mucoid CF 
strains, MH-S macrophages were pretreated with specific blocking antibodies or an 
isotype control. Following antibody treatment, FRD1 or FRD1131 were added for 1 
hour. After treatment with gentamicin, colony counts were performed to determine the 
amount of phagocytosis (Figure 21). When pretreated with α-CD11b or α-CD14, 
phagocytosis of FRD1131 was significantly inhibited but not entirely blocked. 
Phagocytosis of FRD1 was not inhibited further by the addition of receptor blocking 
antibodies, suggesting that these receptors may already be blocked by alginate. While 
these results do confirm the importance of CD11b and CD14 in the phagocytosis of 
FRD, this does not rule out the involvement of additional receptors for phagocytosis. 
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Figure 21. Number of FRD1 or FRD1131 phagocytized by MH-S macrophages in 
the presence of CD11b, CD14, or isotype-control blocking antibodies. MH-S 
macrophages were infected with FRD1 (A) or FRD1131 (B) for 1 hour in the presence of 
CD11b or CD14 blocking antibodies. CFU indicates the number of colony-forming units 
recovered from macrophages. Both antibodies significantly inhibited phagocytosis of 
FRD1131 compared to the isotype control. However, phagocytosis of FRD1 was not 
significantly inhibited by either antibody. Data are shown as mean and standard 
deviation of a representative triplicate experiment. Statistical significance is determined 
by Students t-Test (*; P < 0.05, **; P < 0.01, ***; P < 0.001). 
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 To determine if additional receptors are involved in the phagocytosis of FRD 
CD11b and CD14 blocking antibodies were used together (Figure 22). Interestingly, 
while each antibody alone was able to inhibit phagocytosis of FRD1131 in Figure 21, 
the combination of these two antibodies significantly enhanced phagocytosis of both 
FRD1 and FRD1131. It is possible that by blocking both receptors, there is a synergistic 
signaling response that enhances phagocytosis. 
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Figure 22. Number of FRD1 or FRD1131 phagocytized by MH-S macrophages in 
the presence of CD11b and CD14, or isotype-control blocking antibodies. MH-S 
macrophages were infected with FRD1 (A) or FRD1131 (B) for 1 hour in the presence of 
CD11b and CD14 blocking antibodies. CFU indicates the number of colony-forming 
units recovered from macrophages. When treated with both antibodies together, 
phagocytosis of FRD1 and FRD1131 was significantly increased compared to the 
isotype controls. Data are shown as mean and standard deviation of three samples. 
Statistical significance is determined by Students t-Test (*; P < 0.05, **; P < 0.01, ***; P 
< 0.001). 
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Chapter 7 
Alginate Inhibits the Activation of Critical Phagocytic Signaling 
Pathways 
 
 
 
Intracellular signaling of murine macrophages is delayed and reduced by mucoid 
Pseudomonas aeruginosa 
 It is possible that as a result of alginate inhibiting the binding of P. aeruginosa to 
macrophages, downstream signaling was affected. Previous studies have implicated 
both the PI3K and MAPK pathways in phagocytosis (37). Furthermore, CD11b and 
CD14 can contribute to PI3K signaling (54, 76, 80). To determine if alginate expression 
interferes with activation of signaling pathways involved in phagocytosis, the effect of 
FRD1 and FRD1131 on phosphorylation of AKT and ERK was determined. Alg+ FRD1 
and Alg- FRD1131 were incubated with MH-S macrophages for various time points up 
to 1 hour. Cell lysates were prepared and activation of AKT was assessed by Western 
blot (Figure 23). FRD1131 induces p-AKT in MH-S as early as 15 minutes post infection 
whereas FRD1-induced activation is delayed to 30 minutes. The duration of AKT 
activation is also significantly lower with FRD1 compared to FRD1131 activated 
macrophages which maintained activation at 60 minutes post infection. Alginate 
production modulates AKT activation in MH-S macrophages and may contribute to the 
inhibition of phagocytosis that is observed. 
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Figure 23. Western blot indicating p-AKT and total AKT from MH-S macrophages 
after phagocytosis of FRD1 or FRD1131. Serum starved MH-S macrophages were 
infected with FRD1 (Alg+) or FRD1131 (Alg-) for up to 1 hour. Cell lysates were collected 
and a Western blot was performed using anti-p-AKT and anti-pan-AKT antibodies. 
FRD1 infection resulted in delayed AKT activation at 30 minutes compared to 15 minute 
activation with FRD1131. Data shown is a representative triplicate experiment. 
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 In addition to AKT, ERK activation was also assayed by Western blot. Similarly to 
AKT activation, infection with FRD1 resulted in delayed and decreased ERK activation 
compared to infection with FRD1131 (Figure 24). While p-ERK was faintly detectable at 
30 minutes in the FRD1 samples, FRD1131 induced ERK activation as early as 15 
minutes post infection.  
 Taken together, these results show that alginate production by FRD1 leads to 
delayed and depressed activation of key signaling pathways relating to efficient 
phagocytosis. 
 
Phagocytosis of Pseudomonas aeruginosa by murine macrophages is dependent 
on PI3K, but not MEK, activation 
 To confirm that AKT and ERK pathways are indeed important for the 
phagocytosis of P. aeruginosa by alveolar macrophages, the effect of specific pathway 
inhibitors on phagocytosis was evaluated. To confirm that the selected inhibitors 
effectively inhibited phosphoinositide 3-kinase (PI3K) and MAPK/ERK kinase (MEK) 
activation, MH-S macrophages were pretreated with wortmannin, LY294002, or U0126, 
for 30 minutes before the addition of FRD1131 for an additional 30 minutes. Cell lysates 
were prepared and activation of AKT and ERK was assessed by Western blot (Figure 
25). The PI3K inhibitors, wortmannin and LY294002, successfully inhibited AKT 
activation at both concentrations tested. The MEK inhibitor, U0126, was able to inhibit 
ERK activation. 
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Figure 24. Western blot indicating p-ERK2 and total ERK1/ERK2 from MH-S 
macrophages after phagocytosis of FRD1 or FRD1131. Serum starved MH-S 
macrophages were infected with FRD1 (Alg+) or FRD1131 (Alg-) for up to 30 minutes. 
Cell lysates were collected and a Western blot was performed using anti-p-ERK and 
anti-pan-ERK antibodies. FRD1 infection resulted in decreased ERK activation at 30 
minutes compared to FRD1131. Data shown is a representative triplicate experiment. 
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Figure 25. Western blots showing p-ERK2, total ERK1/ERK2, p-AKT, and total AKT 
from MH-S macrophages after phagocytosis of FRD1 or FRD1131 in the presence 
of wortmannin, LY294002, or U0126. Serum starved MH-S macrophages were 
infected with FRD1131 for 30 minutes in the presence of wortmannin (A), LY294002 (A), 
or U0126 (B). Cell lysates were collected and a Western blot was performed using anti-
p-AKT (A), anti-pan-AKT (A), anti-p-ERK (B), and anti-pan-ERK (B) antibodies. Both 
wortmannin and LY294002 successfully inhibited AKT activation. Despite low baseline 
phosphorylation, U0126 was able to inhibit ERK activation. 
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 MH-S macrophages were pretreated with wortmannin, LY294002, or U0126, for 
30 minutes before the addition of FRD1, FRD1131, or PAO1. After treatment with 
gentamicin, colony counts were performed to determine the amount of phagocytosis 
(Figure 26). Both of the AKT inhibitors, wortmannin and LY294002, significantly 
inhibited phagocytosis of all P. aeruginosa strains tested. However the ERK inhibitor, 
U0126, did not inhibit phagocytosis of FRD1, FRD1131, or PAO1. 
 It is possible that ERK signaling may be dispensable for efficient phagocytosis of 
these strains. However, there are additional explanations for this observation. The 
threshold for ERK to contribute to phagocytosis could be very low or could be 
redundant, as there are many interacting signaling pathways. PI3K, and subsequently 
AKT, signaling is likely critical to phagocytosis of P. aeruginosa. Thus, alginate 
production by P. aeruginosa leads to reduced binding and depressed PI3K signaling, 
leading to inhibited phagocytosis. 
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Figure 26. Number of bacteria phagocytized by MH-S macrophages after 1 hour in 
the presence of AKT or ERK inhibitors. MH-S macrophages were infected with FRD1 
(A), FRD1131 (B), or PAO1 (C) for 1 hour in the presence of wortmannin, LY294002, or 
U0126. CFU indicates the number of colony-forming units recovered from 
macrophages. Both AKT inhibitors, wortmannin and LY294002, significantly inhibited 
phagocytosis of FRD1, FRD1131 and PAO1. However, the ERK inhibitor U0126 was 
unable to inhibit phagocytosis of any strain tested. Data are shown as mean and 
standard deviation of a representative triplicate experiment. Statistical significance is 
determined by Students t-Test (*; P < 0.05, **; P < 0.01, ***; P < 0.001). 
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Acid sphingomyelinase activity in murine macrophages is unaffected by mucoid 
Pseudomonas aeruginosa 
 Increased ceramide concentration within lipid rafts has been implicated as a 
critical mediator of phagocytosis of P. aeruginosa by epithelial cells and of latex beads 
by murine macrophages (23, 57). Ceramide is produced by acid sphingomyelinase 
(ASMase) and ASMase activity is increased during infection (23). However, another 
study showed that high ceramide concentration was associated with decreased P. 
aeruginosa killing in mice (3). P. aeruginosa LPS-induced Acid sphingomyelinase 
activity, and subsequently ceramide concentration, has been shown to be NF-κB 
dependent (85). As shown in Figure 23, AKT activation, which leads to NF-κB 
activation, is altered in the presence of alginate. Therefore, it is possible for ASMase 
activity to be affected by alginate production. To determine ASMase activity, MH-S 
macrophages were first serum starved for 6 hours, and then cultured with FRD1, 
FRD1131 or PAO1 for 15 minutes. Previous studies have indicated that ASMase activity 
peaks around 10 to 20 minutes following infection (23). Cell lysates were generated and 
ASMase activity was measured (Figure 27). ASMase activity was not significantly 
affected by the addition of P. aeruginosa, or the presence of alginate. Consequently, 
ceramide concentrations are likely to be unaffected by the presence of alginate. It is 
possible that while ASMase activity is NF-κB dependent, NF-κB may be sufficiently 
activated despite reduced AKT signaling. 
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Figure 27. Acid sphingomyelinase activity from MH-S macrophages after 
phagocytosis for 15 minutes. Serum starved MH-S macrophages were infected with 
FRD1, FRD1131, or PAO1 for 15 minutes. Macrophage lysates were collected and 
analyzed to determine ASMase activity. No significant difference in ASMase activity was 
induced by any strain compared to resting macrophages alone. Data are shown as 
mean and standard deviation of three separate experiments. Statistical significance is 
determined by Students t-Test (*; P < 0.05, **; P < 0.01, ***; P < 0.001). 
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IL-8 production by human macrophages is unaffected by mucoid Pseudomonas 
aeruginosa 
 Cytokine production plays an important role in promoting lung damage in cystic 
fibrosis (2, 6, 77). Large amounts of neutrophils traffic to the lung, leading to lung 
damage despite their inability to clear the infection. IL-8 is a chemokine produced by 
macrophages that functions as a major neutrophil chemoattractant. Mucoid P. 
aeruginosa inhibits AKT activation which could affect downstream activation of NF-κB 
activation. NF-κB is responsible for IL-8 production, therefore, cytokine production could 
be altered in macrophages due to altered binding, and signaling, from the presence of 
alginate (88). To determine if IL-8 production was affected by alginate production, an IL-
8 ELISA kit was used. First, a time course of IL-8 production was established. THP-1 
macrophages were cultured with FRD1, FRD1131 or 1 mg/ml zymosan for up to 8 
hours. Supernatants were removed at 2 hour intervals and frozen for analysis (Figure 
28). At every time point measured, IL-8 induced by FRD1 and FRD1131 appeared 
similar. 
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Figure 28. Time course of IL-8 produced by THP-1 macrophages after 
phagocytosis of FRD1 or FRD1131. THP-1 macrophages were infected with FRD1, 
FRD1131, or treated with zymosan for up to 8 hours. Supernatants were collected at 
various time points and analyzed by ELISA for IL-8 production. At each point measured, 
both FRD1 and FRD1131 induced similar amounts of IL-8. 
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 To confirm the effect of alginate on the production of IL-8 by THP-1 
macrophages, the ELISA was repeated using 8 hour cultures (Figure 29). As indicated, 
there was no significant difference in the amount of IL-8 induced by FRD1 compared to 
FRD1131. It is possible that the majority of IL-8 produced by macrophages was contact 
independent. If this were the case, the inhibited binding due to alginate would not affect 
IL-8 production. To determine if contact with P. aeruginosa was necessary for IL-8 
production, FRD1 and FRD1131 were cultured in RPMI for 8 hours. After 8 hours 
supernatants were collected and applied to THP-1 macrophages for an additional 8 
hours. As shown in Figure 29, the P. aeruginosa supernatants were able to induce IL-8 
in THP-1 macrophages. There was no significant difference in the amount of IL-8 
induced by the supernatants compared to the amount induced by the P. aeruginosa 
strains themselves. Therefore IL-8 production by THP-1 macrophages appeared to be 
contact independent and was unaffected by the production of alginate. 
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Figure 29. Amount of IL-8 produced by THP-1 macrophages 8 hours after 
phagocytosis of FRD1, FRD1131, or in the presence of bacterial supernatants. 
THP-1 macrophages were infected with FRD1, FRD1131, or treated with FRD1 or 
FRD1131 supernatants for 8 hours. Supernatants were collected and analyzed by 
ELISA for IL-8 production. No significant difference was found between the amount of 
IL-8 induced by FRD1 compared to FRD1131. Similarly, no significant difference was 
found between the amount of IL-8 induced by FRD1 and FRD1131 compared to IL-8 
induced by the respective supernatants. Data are shown as mean and standard 
deviation of three separate experiments. Statistical significance is determined by 
Students t-Test (*; P < 0.05, **; P < 0.01, ***; P < 0.001). 
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MIP-2 production by murine macrophages is unaffected by mucoid Pseudomonas 
aeruginosa 
 Murine macrophages do not produce IL-8 and instead produce a similar 
neutrophil chemoattractant called MIP-2. I next wanted to asses MH-S macrophages for 
MIP-2 production in response to FRD1 and FRD1131. MH-S macrophages were 
cultured with FRD1 or FRD1131 for 8 hours. After incubation, supernatants were frozen 
for analysis by MIP-2 ELISA kit (Figure 30). As with IL-8 production, there was no 
significant difference in the amount of MIP-2 produced between FRD1 and FRD1131. 
Eight hour supernatants were again tested to determine contact dependence of MIP-2 
production. There was no significant difference in MIP-2 production induced by the 
supernatants compared to the strains themselves. 
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Figure 30. Amount of MIP-2 produced by MH-S macrophages 8 hours after 
phagocytosis of FRD1, FRD1131, or in the presence of bacterial supernatants. 
MH-S macrophages were infected with FRD1, FRD1131, or treated with FRD1 or 
FRD1131 supernatants for 8 hours. Supernatants were collected and analyzed by 
ELISA for MIP-2 production. No significant difference was found between the amount of 
IL-8 induced by FRD1 compared to FRD1131. Similarly, no significant difference was 
found between the amount of IL-8 induced by FRD1 and FRD1131 compared to IL-8 
induced by the respective supernatants. Data are shown as mean and standard 
deviation of three separate experiments. Statistical significance is determined by 
Students t-Test (*; P < 0.05, **; P < 0.01, ***; P < 0.001). 
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 A possible problem with the use of 8 hour supernatants for an additional 8 hours 
is that the soluble, stimulatory factors in the supernatants would be highly concentrated 
immediately, whereas the wells with the P. aeruginosa strains added directly would 
slowly build up to that high concentration over the 8 hour incubation. As a more direct 
assessment of the contact dependence of MIP-2 production, 0.4 µm filter inserts were 
used to separate the added P. aeruginosa from the macrophages while allowing for 
soluble factors to diffuse throughout the media (Figure 31). There remained no 
significant difference in the amount of MIP-2 produced between FRD1 and FRD1131 
with, or without, the filter. However, the addition of the filter significantly reduced the 
amount of MIP-2 produced by both FRD1 and FRD1131. The filter did not entirely 
eliminate MIP-2 production, suggesting that MIP-2 production is partially contact 
independent. Furthermore, based on the high concentration supernatants used in 
Figure 29 and 30, soluble factors can compensate for the lack of contact. 
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Figure 31. Amount of MIP-2 produced by MH-S macrophages 8 hours after 
phagocytosis of FRD1, FRD1131, or in the presence of bacterial supernatants 
from bacteria separated by a filter. MH-S macrophages were infected with FRD1 or 
FRD1131 either directly or above a filter for 8 hours. Supernatants were collected and 
analyzed by ELISA for MIP-2 production. No significant difference was found between 
the amount of IL-8 induced by FRD1 compared to FRD1131. However, the amount of 
IL-8 induced by FRD1 was significantly higher than the amount induced by FRD1 when 
separated by a filter. Similarly, the amount of IL-8 induced by FRD1131 was significantly 
higher than the amount induced by FRD1131 when separated by a filter. Data are 
shown as mean and standard deviation of three separate experiments. Statistical 
significance is determined by Students t-Test (*; P < 0.05, **; P < 0.01, ***; P < 0.001). 
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Chapter 8 
Discussion and Future Studies 
 
 
 
 The goal of this research was to determine the mechanism by which alginate, an 
exopolysaccharide secreted by mucoid Pseudomonas aeruginosa, inhibits phagocytosis 
by macrophages. The mucoid phenotype has been shown to enhance survival of P. 
aeruginosa and infection of the lung significantly increases the mortality rate of CF 
patients (8, 43, 68, 70). Therefore, understanding how alginate protects P. aeruginosa 
from phagocytosis is important for the treatment of cystic fibrosis lung infections. To 
address my goal, I investigated the effect of alginate by using two cell line models for 
phagocytosis. Initially, since cystic fibrosis is a human disease, the human monocytic 
cell line THP-1 was used as model for phagocytosis. Since alveolar macrophages have 
altered receptor expression, activation and survival compared to peripheral 
macrophages, I used the murine alveolar macrophage cell line MH-S to investigate 
phagocytosis by macrophages more appropriate to the lung infection environment (25, 
56). The FRD strain of P. aeruginosa was used to address the effect of alginate on 
phagocytosis by these two cell lines. FRD1 is a mucoid cystic fibrosis clinical isolate and 
FRD1131 is a non-mucoid isogenic algD::Tn501-33 mutant. The only difference 
between these mutants is the production of alginate which allowed me to study the 
effect of alginate on phagocytosis. This research demonstrates for the first time that 
alginate on the bacterial surface inhibits phagocytosis by reducing binding to 
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macrophages and interfering with important phagocytosis receptors, resulting in 
decreased intracellular signaling and reduced phagocytosis. 
 Previous studies attempted to understand the role of alginate in resisting the 
immune response. Several groups suggested that mucoid P. aeruginosa are protected 
against non-opsonic phagocytosis (8, 43, 68). Likewise, Leid et al. (46) showed that 
mucoid P. aeruginosa have significantly enhanced biofilm survival against opsonic 
killing. These publications, however, did not quantitatively address the role of alginate in 
the non-opsonic phagocytosis of planktonic P. aeruginosa. My research demonstrates 
that alginate production by P. aeruginosa significantly protects against both opsonic and 
non-opsonic phagocytosis by human and murine macrophages. Phagocytosis was 
assessed through two assays that measured different aspects of phagocytosis. The 
total number of bacteria phagocytized was determined by lysing macrophages and 
counting CFUs. The fraction of macrophages engaged in phagocytosis was determined 
by using flow cytometry. It is also possible to use the mean fluorescence intensity (MFI) 
from the flow cytometry data to determine the relative number of GFP-expressing 
bacteria phagocytized by each macrophage. However, when performing the 
experiments presented here, the MFI data often revealed very little difference amongst 
the different strains or the negative control. It is possible that the system is unable to 
detect the difference in fluorescence from just a few bacteria. Another explanation could 
be that the amount of GFP within each bacterium could be inconsistent, depending on 
how long the protein has been expressed by an individual bacterium. 
 Alginate production and flagellum expression are inversely expressed in P. 
aeruginosa. Therefore, when considering the role of alginate in phagocytosis, it is also 
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important to consider the role of flagellum (78, 79). Mahenthiralingam et al. (50, 51) 
have shown that expression of flagellum significantly enhances phagocytosis by 
macrophages and conclude that flagellum is critical to internalization, but not binding. 
However, other studies indicated that motility, independent of flagellum expression and 
TLR signaling, is responsible for evasion of phagocytosis (1, 47). While I did observe 
decreased phagocytosis in the absence of flagellum expression, significant levels of 
phagocytosis occur in the absence of flagellum expression and motility. My results 
suggest that flagellum is expressed by FRD1, which enhances phagocytosis. This 
would mean that despite alginate production, indicating active σ22 and the down 
regulation of flagellum expression, flagellum is expressed enough to enhance 
phagocytosis. These results also disagree with the findings by the Berwin lab (1, 47), 
which conclude that motility, and not flagellum, is responsible for stimulating 
phagocytosis. It is possible that this disagreement is due to differences in the 
macrophages and P. aeruginosa strains studied. While this study uses human and 
murine macrophages cell lines, their studies used human peripheral blood monocyte-
derived macrophages. Primary human macrophages could express different amounts of 
TLR5, which could affect the amount of phagocytosis. For the motility studies, Lovewell 
et al. (47) and Amiel et al. (1) both use the P. aeruginosa strain PA14. It is possible that 
the expression of ligands involved in phagoytosis, such as pilin or serotypes of LPS, 
could account for the observed differences. 
 Interestingly, when cultured together, alginate produced by FRD1 was unable to 
inhibit phagocytosis of non-mucoid FRD1131. This implies that alginate did not induce a 
negative signal within the macrophages because the presence of alginate in the media 
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would inhibit phagocytosis if this were the case. Also, alginate added exogenously was 
unable to protect non-mucoid P. aeruginosa from phagocytosis. Again, this suggests 
that alginate is not negatively regulating macrophages or else this would inhibit 
phagocytosis of non-mucoid FRD1131. Since alginate decreases P. aeruginosa binding 
to murine macrophages it is more likely that alginate interferes with a receptor-ligand 
interaction that is necessary for promoting phagocytosis. 
 In an attempt to identify a receptor(s) that may be blocked by alginate, I 
investigated the contribution of CD11b and CD14, which have been reported to facilitate 
phagocytosis of P. aeruginosa (29). CR3 has been shown to bind to a number of 
ligands associated with P. aeruginosa including LPS, APG, and β-glucan (7, 89). 
Blocking either CD11b or CD14 led to a significant decrease in phagocytosis of non-
mucoid P. aeruginosa by murine macrophages, but this effect was absent with mucoid 
P. aeruginosa. This suggests that both of these receptors were being blocked 
completely by alginate and that further blockade with the antibodies was ineffective. 
Furthermore, phagocytosis of FRD1 or FRD1131 was not inhibited when both CD11b 
and CD14 antibodies were used together. It is possible that the antibodies did not 
completely block the receptors. This would allow for some function to remain and allow 
for phagocytosis, but this does not explain why phagocytosis was significantly enhanced 
when both antibodies were used. It is possible that the combination of antibodies 
resulted in stimulating or activating the macrophages. In an infection, it is likely that both 
of these receptors, and many others, would be simultaneously stimulated in a pathogen 
rich environment. 
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 I also investigated the effects of alginate on the downstream signaling events 
contributing to efficient phagocytosis. Both CD11b and CD14 can activate PI3K and 
MEK1/2. CD14/TLR4 signaling through MyD88, IRAK1/4, and TRAF6 activate PI3K and 
MEK1/2 (71). CR3 can also lead to PI3K and MEK activation through PLC and protein 
kinase C (PKC) (26, 71, 83). AKT and ERK phosphorylation were used to measure 
PI3K and MEK1/2 activation. Both ERK and AKT activation were decreased by alginate 
production. While PI3K activation was found to be critical for phagocytosis of P. 
aeruginosa, loss of MEK activation had no significant effect. Reduced ERK activation by 
alginate may lead to altered inflammatory signaling despite not being necessary for 
phagocytosis. NF-κB activation occurs downstream of AKT phosphorylation and leads 
to ASMase activity (85). However, I found that ASMase activity was not altered in 
murine macrophages infected with mucoid P. aeruginosa compared to non-mucoid 
strains. This could be due to high ASMase activity in murine macrophages, or that the 
cells were not allowed to rest long enough before phagocytosis. In either case the 
ASMase activity in the negative control would be higher than expected. Similarly, I 
found no significant difference in the amount of IL-8 or MIP-2 induced by mucoid and 
non-mucoid P. aeruginosa. This could be because MIP-2 induction was found to be 
partially contact-independent, which is often the case in cytokine induction (84). It is 
possible that while ASMase activity and IL-8 production are NF-κB dependent, NF-κB 
may be sufficiently activated despite reduced AKT signaling. It is also possible that NF-
κB activity is stimulated through a PI3K-independent pathway. This could be 
accomplished through other scavenger and pattern recognition receptor signaling. 
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 While this dissertation presents many new findings, several avenues of research 
remain open relating to the effect of alginate production on phagocytosis. First, the 
addition of LPS O-side chain production to the FRD stain (FRD1810) and the addition of 
alginate production to the PAO strain (PDO300) do not lead to equal phagocytosis. 
Despite both strains producing alginate and LPS containing O-Side chains, PDO300 is 
phagocytized significantly more than FRD1810. There may be additional stimulatory 
factors present in PDO300, or addition inhibitory factors present in FRD1810, leading to 
altered phagocytosis. Further analysis of surface receptors present on both strains 
could reveal additional receptors present or lacking in the two strains. Additionally, I 
observed a trend of reduced induction of lipid raft formation by Alg+ FRD1 compared to 
Alg- FRD1131. While I found no significant difference in the amount of ASMase activity 
induced between the two strains, it may be possible to quantify a difference in lipid raft 
formation or ceramide concentration. Furthermore, it would be interesting to determine if 
actin polymerization, and the formation of the phagocytic cup, is decreased when 
phagocytizing mucoid P. aeruginosa. Additionally, Leid et al. (46) established that 
alginate production also protects P. aeruginosa in a biofilm from opsonic phagocytosis. 
The experiments presented here could be repeated in the context of mucoid and non-
mucoid P. aeruginosa in a biofilm (62). Finally, the research presented in this 
dissertation has focused on phagocytosis by human and murine macrophage cell lines. 
It would be beneficial to extend these studies by using primary human and murine 
macrophages. Primary human alveolar macrophages could be isolated from sputum of 
healthy donors and cystic fibrosis patients (73). Likewise, bronchoalveolar lavage fluid 
(BALF) can be acquired from mice and used to generate primary murine alveolar 
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macrophages (65). This would also allow for studies using CFTR knockout mice to 
evaluate phagocytosis by CFTR-deficient alveolar macrophages (24). Macrophages 
from CD11b and CD14 single, or double knockout mice could also be useful. This would 
allow for phagocytosis assays which could identify other important phagocytosis 
receptors. Other receptors found this way could again be confirmed by using 
macrophages from knockout mice. 
 Alginate may also relate to the clearance of apoptotic cells. It is possible that 
alginate interferes with binding of the lactadherin-phosphatidylserine complex to the 
αVβ3 integrin. αVβ3 integrin and CR3 have both been shown to bind HMGB1 (20, 89). It 
is conceivable then that if alginate is able to interfere with CR3, as I have shown to be 
possible in this study, then it could interfere with αVβ3 integrin as well. By doing so, 
alginate would inhibit phagocytic clearance of apoptotic cells (16). Thus, alginate could 
exacerbate the ineffective clearance of apoptotic neutrophils in the cystic fibrosis lung. 
 In summary, this dissertation demonstrated that alginate production by the cystic 
fibrosis clinical isolate of Pseudomonas aeruginosa, FRD1, inhibited phagocytosis by 
significantly decreasing binding to murine macrophages. Both CD11b and CD14 appear 
to be important for phagocytosis and may be blocked by alginate. Decreased binding 
leads to reduced downstream mediators of phagocytosis, including decreased AKT and 
ERK activation. To have this protective effect, alginate must be produced directly by the 
bacteria and did not appear to benefit other local non-mucoid bacteria. Understanding 
how alginate protects P. aeruginosa from phagocytosis is important for the treatment of 
lung infections commonly found in cystic fibrosis patients. By understanding the 
pathways involved in mediating efficient phagocytosis of clinical isolates, it may be 
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possible to develop a treatment to promote clearance by the resident alveolar 
macrophages. These experiments may also serve as a model to evaluate the 
effectiveness of such treatments. This approach also provides valuable insight into 
previously unknown macrophage phagocytosis mechanisms. 
 
  
 117 
 
List of References 
  
 118 
 
 
 
 
 
 
List of References 
 
 
 
1. Amiel, E, Lovewell, RR, O'Toole, GA, Hogan, DA, Berwin, B. 2010. Pseudomonas 
aeruginosa evasion of phagocytosis is mediated by loss of swimming motility and is 
independent of flagellum expression. Infect. Immun. 78(7):2937-45. doi: 
10.1128/IAI.00144-10.  
 
2. Balough, K, McCubbin, M, Weinberger, M, Smits, W, Ahrens, R, Fick, R. 1995. 
The relationship between infection and inflammation in the early stages of lung disease 
from cystic fibrosis. Pediatr. Pulmonol. 20(2):63-70. doi: 10.1002/ppul.1950200203.  
 
3. Becker, KA, Riethmüller, J, Lüth, A, Döring, G, Kleuser, B, Gulbins, E. 2010. 
Acid sphingomyelinase inhibitors normalize pulmonary ceramide and inflammation in 
cystic fibrosis. Am J Respir Cell Mol Biol. 42(6):716-24. doi: 10.1165/rcmb.2009-
0174OC.  
 
4. Berwin, B, Hart, JP, Rice, S, Gass, C, Pizzo, SV, Post, SR, Nicchitta, CV. 2003. 
Scavenger receptor-A mediates gp96/GRP94 and calreticulin internalization by antigen-
presenting cells. EMBO J. 22:6127-6136. doi: 10.1093/emboj/cdg572.  
 
5. Bonhoeffer, F. 1966. DNA transfer and DNA synthesis during bacterial conjugation. 
Z. Vererbungsl. 98:141-149.  
 
6. Brennan, S. 2008. Innate immune activation and cystic fibrosis. Paediatr Respir Rev. 
9(4):271-9. doi: 10.1016/j.prrv.2008.05.008.  
 
7. Brown, GD. 2006. Dectin-1: a signalling non-TLR pattern-recognition receptor. Nat. 
Rev. Immunol. 6:33-43. doi: 10.1038/nri1745.  
 
 
 119 
 
8. Cabral, DA, Loh, BA, Speert, DP. 1987. Mucoid Pseudomonas aeruginosa resists 
nonopsonic phagocytosis by human neutrophils and macrophages. Pediatr. Res. 
22(4):429-31.  
 
9. Cain, RJ, Ridley, AJ. 2009. Phosphoinositide 3-kinases in cell migration. Biol. Cell. 
101:13-29. doi: 10.1042/BC20080079; 10.1042/BC20080079.  
 
10. Chitnis, CE, Ohman, DE. 1993. Genetic analysis of the alginate biosynthetic gene 
cluster of Pseudomonas aeruginosa shows evidence of an operonic structure. Mol. 
Microbiol. 8:583-593.  
 
11. Ciofu, O, Riis, B, Pressler, T, Poulsen, HE, Høiby, N. 2005. Occurrence of 
hypermutable Pseudomonas aeruginosa in cystic fibrosis patients is associated with the 
oxidative stress caused by chronic lung inflammation. Antimicrob. Agents Chemother. 
49(6):2276-82.  
 
12. Cystic Fibrosis Foundation. About Cystic Fibrosis. Cystic Fibrosis Foundation. 
2013. <http://www.cff.org/AboutCF/>. 
 
13. Damron, FH, Goldberg, JB. 2012. Proteolytic regulation of alginate overproduction 
in Pseudomonas aeruginosa. Mol. Microbiol. 84:595-607. doi: 10.1111/j.1365-
2958.2012.08049.x; 10.1111/j.1365-2958.2012.08049.x.  
 
14. de Assis, MC, Saliba, AM, Vidipó, LA, De Salles, JB, Plotkowski, MC. 2004. 
Pseudomonas aeruginosa-induced production of free radicals by IFN gamma plus TNF 
alpha-activated human endothelial cells: mechanism of host defense or of bacterial 
pathogenesis? Immunol. Cell Biol. 82(4):383-92.  
 
15. Figurski, DH, Helinski, DR. 1979. Replication of an origin-containing derivative of 
plasmid RK2 dependent on a plasmid function provided in trans. Proc. Natl. Acad. Sci. 
U. S. A. 76:1648-1652.  
 
16. Flannagan, RS, Jaumouille, V, Grinstein, S. 2012. The cell biology of 
phagocytosis. Annu. Rev. Pathol. 7:61-98. doi: 10.1146/annurev-pathol-011811-
132445; 10.1146/annurev-pathol-011811-132445.  
 
 120 
 
17. Fleiszig, SM, Wiener-Kronish, JP, Miyazaki, H, Vallas, V, Mostov, KE, Kanada, 
D, Sawa, T, Yen, TS, Frank, DW. 1997. Pseudomonas aeruginosa-mediated 
cytotoxicity and invasion correlate with distinct genotypes at the loci encoding 
exoenzyme S. Infect. Immun. 65(2):579-86.  
 
18. Folkesson, A, Jelsbak, L, Yang, L, Johansen, HK, Ciofu, O, Hoiby, N, Molin, S. 
2012. Adaptation of Pseudomonas aeruginosa to the cystic fibrosis airway: an 
evolutionary perspective. Nat. Rev. Microbiol. 10:841-851. doi: 10.1038/nrmicro2907; 
10.1038/nrmicro2907.  
 
19. Franklin, MJ, Chitnis, CE, Gacesa, P, Sonesson, A, White, DC, Ohman, DE. 
1994. Pseudomonas aeruginosa AlgG is a polymer level alginate C5-mannuronan 
epimerase. J. Bacteriol. 176(7):1821-30.  
 
20. Friggeri, A, Yang, Y, Banerjee, S, Park, YJ, Liu, G, Abraham, E. 2010. HMGB1 
inhibits macrophage activity in efferocytosis through binding to the alphavbeta3-integrin. 
Am. J. Physiol. Cell. Physiol. 299:C1267-76. doi: 10.1152/ajpcell.00152.2010; 
10.1152/ajpcell.00152.2010.  
 
21. Glessner, A, Smith, RS, Iglewski, BH, Robinson, JB. 1999. Roles of 
Pseudomonas aeruginosa las and rhl quorum-sensing systems in control of twitching 
motility. J. Bacteriol. 181(5):1623-9.  
 
22. Goehring, UM, Schmidt, G, Pederson, KJ, Aktories, K, Barbieri, JT. 1999. The 
N-terminal domain of Pseudomonas aeruginosa exoenzyme S is a GTPase-activating 
protein for Rho GTPases. J. Biol. Chem. 274:36369-36372.  
 
23. Grassmé, H, Jendrossek, V, Riehle, A, von Kürthy, G, Berger, J, Schwarz, H, 
Weller, M, Kolesnick, R, Gulbins, E. 2003. Host defense against Pseudomonas 
aeruginosa requires ceramide-rich membrane rafts. Nat. Med. 9(3):322-30.  
 
24. Guilbault, C, Saeed, Z, Downey, GP, Radzioch, D. 2007. Cystic fibrosis mouse 
models. Am. J. Respir. Cell Mol. Biol. 36:1-7. doi: 10.1165/rcmb.2006-0184TR.  
 
25. Gwinn, MR, Vallyathan, V. 2006. Respiratory burst: role in signal transduction in 
alveolar macrophages. J Toxicol Environ Health B Crit Rev. 9(1):27-39.  
 
 121 
 
26. Hajishengallis, G. 2010. Complement and periodontitis. Biochem. Pharmacol. 
80:1992-2001. doi: 10.1016/j.bcp.2010.06.017; 10.1016/j.bcp.2010.06.017.  
 
27. Hajishengallis, G, Wang, M, Harokopakis, E, Triantafilou, M, Triantafilou, K. 
2006. Porphyromonas gingivalis fimbriae proactively modulate beta2 integrin adhesive 
activity and promote binding to and internalization by macrophages. Infect. Immun. 
74:5658-5666. doi: 10.1128/IAI.00784-06.  
 
28. Hartl, D, Gaggar, A, Bruscia, E, Hector, A, Marcos, V, Jung, A, Greene, C, 
McElvaney, G, Mall, M, Doring, G. 2012. Innate immunity in cystic fibrosis lung 
disease. J. Cyst Fibros. 11:363-382. doi: 10.1016/j.jcf.2012.07.003; 
10.1016/j.jcf.2012.07.003.  
 
29. Heale, JP, Pollard, AJ, Stokes, RW, Simpson, D, Tsang, A, Massing, B, Speert, 
DP. 2001. Two distinct receptors mediate nonopsonic phagocytosis of different strains 
of Pseudomonas aeruginosa. J. Infect. Dis. 183(8):1214-20.  
 
30. Held, K, Ramage, E, Jacobs, M, Gallagher, L, Manoil, C. 2012. Sequence-verified 
two-allele transposon mutant library for Pseudomonas aeruginosa PAO1. J. Bacteriol. 
194:6387-6389. doi: 10.1128/JB.01479-12; 10.1128/JB.01479-12.  
 
31. Hidron, AI, Edwards, JR, Patel, J, Horan, TC, Sievert, DM, Pollock, DA, Fridkin, 
SK, National Healthcare Safety Network Team, Participating National Healthcare 
Safety Network Facilities. 2008. NHSN annual update: antimicrobial-resistant 
pathogens associated with healthcare-associated infections: annual summary of data 
reported to the National Healthcare Safety Network at the Centers for Disease Control 
and Prevention, 2006-2007. Infect. Control Hosp. Epidemiol. 29:996-1011. doi: 
10.1086/591861; 10.1086/591861.  
 
32. Holloway, BW, Krishnapillai, V, Morgan, AF. 1979. Chromosomal genetics of 
Pseudomonas. Microbiol. Rev. 43:73-102.  
 
33. Houde, M, Gottschalk, M, Gagnon, F, Van Calsteren, MR, Segura, M. 2012. 
Streptococcus suis capsular polysaccharide inhibits phagocytosis through 
destabilization of lipid microdomains and prevents lactosylceramide-dependent 
recognition. Infect. Immun. 80(2):506-17. doi: 10.1128/IAI.05734-11.  
 
 122 
 
34. Jain, S, Ohman, DE. 2004. Alginate Biosynthesis, p. 53-83. In J. Ramos (ed.), 
Pseudomonas, Biosynthesis of Macromolecules and Molecular Metabolism ed., vol. 3. 
10.1007/978-1-4419-9088-4.  
 
35. Jain, S, Ohman, DE. 2005. Role of an alginate lyase for alginate transport in 
mucoid Pseudomonas aeruginosa. Infect. Immun. 73:6429-6436. doi: 
10.1128/IAI.73.10.6429-6436.2005.  
 
36. Kaneshiro, NK, Zieve, D. 2012. Cystic Fibrosis. PubMed Health. 2013. 
<http://www-ncbi-nlm-nih-gov.proxy.library.vcu.edu/pubmedhealth/PMH0001167/>. 
 
37. Kannan, S, Audet, A, Huang, H, Chen, LJ, Wu, M. 2008. Cholesterol-rich 
membrane rafts and Lyn are involved in phagocytosis during Pseudomonas aeruginosa 
infection. J Immunol. 180(4):2396-408.  
 
38. Kanno, S, Furuyama, A, Hirano, S. 2007. A murine scavenger receptor MARCO 
recognizes polystyrene nanoparticles. Toxicol Sci. 97(2):398-406.  
39. Keiski, CL, Harwich, M, Jain, S, Neculai, AM, Yip, P, Robinson, H, Whitney, JC, 
Riley, L, Burrows, LL, Ohman, DE, Howell, PL. 2010. AlgK is a TPR-containing 
protein and the periplasmic component of a novel exopolysaccharide secretin. 
Structure. 18:265-273. doi: 10.1016/j.str.2009.11.015; 10.1016/j.str.2009.11.015.  
 
40. Knutson, CA, Jeanes, A. 1968. A new modification of the carbazole analysis: 
application to heteropolysaccharides. Anal. Biochem. 24:470-481.  
 
41. Kobzik, L. 1995. Lung macrophage uptake of unopsonized environmental 
particulates. Role of scavenger-type receptors. J. Immunol. 155:367-376.  
 
42. Kravchenko, VV, Kaufmann, GF, Mathison, JC, Scott, DA, Katz, AZ, Grauer, 
DC, Lehmann, M, Meijler, MM, Janda, KD, Ulevitch, RJ. 2008. Modulation of gene 
expression via disruption of NF-kappaB signaling by a bacterial small molecule. 
Science. 321:259-263. doi: 10.1126/science.1156499; 10.1126/science.1156499.  
 
43. Krieg, DP, Helmke, RJ, German, VF, Mangos, JA. 1988. Resistance of mucoid 
Pseudomonas aeruginosa to nonopsonic phagocytosis by alveolar macrophages in 
vitro. Infect. Immun. 56(12):3173-9.  
 
 123 
 
44. Lagendijk, EL, Validov, S, Lamers, GE, de Weert, S, Bloemberg, GV. 2010. 
Genetic tools for tagging Gram-negative bacteria with mCherry for visualization in vitro 
and in natural habitats, biofilm and pathogenicity studies. FEMS Microbiol. Lett. 
305(1):81-90. doi: 10.1111/j.1574-6968.2010.01916.x.  
 
45. Lavoie, EG, Wangdi, T, Kazmierczak, BI. 2011. Innate immune responses to 
Pseudomonas aeruginosa infection. Microbes Infect. 13:1133-1145. doi: 
10.1016/j.micinf.2011.07.011; 10.1016/j.micinf.2011.07.011.  
 
46. Leid, JG, Willson, CJ, Shirtliff, ME, Hassett, DJ, Parsek, MR, Jeffers, AK. 2005. 
The exopolysaccharide alginate protects Pseudomonas aeruginosa biofilm bacteria 
from IFN-gamma-mediated macrophage killing. J Immunol. 175(11):7512-8.  
 
47. Lovewell, RR, Collins, RM, Acker, JL, O'Toole, GA, Wargo, MJ, Berwin, B. 
2011. Step-wise loss of bacterial flagellar torsion confers progressive phagocytic 
evasion. PLoS Pathog. 7(9):e1002253. doi: 10.1371/journal.ppat.1002253.  
 
48. Luzar, MA, Thomassen, MJ, Montie, TC. 1985. Flagella and motility alterations in 
Pseudomonas aeruginosa strains from patients with cystic fibrosis: relationship to 
patient clinical condition. Infect. Immun. 50(2):577-82.  
 
49. Machen, TE. 2006. Innate immune response in CF airway epithelia: 
hyperinflammatory? Am J Physiol Cell Physiol. 291(2):C218-30.  
 
50. Mahenthiralingam, E, Campbell, ME, Speert, DP. 1994. Nonmotility and 
phagocytic resistance of Pseudomonas aeruginosa isolates from chronically colonized 
patients with cystic fibrosis. Infect. Immun. 62:596-605.  
 
51. Mahenthiralingam, E, Speert, DP. 1995. Nonopsonic phagocytosis of 
Pseudomonas aeruginosa by macrophages and polymorphonuclear leukocytes requires 
the presence of the bacterial flagellum. Infect. Immun. 63:4519-4523.  
 
52. Mansfield, PJ, Shayman, JA, Boxer, LA. 2000. Regulation of polymorphonuclear 
leukocyte phagocytosis by myosin light chain kinase after activation of mitogen-
activated protein kinase. Blood. 95:2407-2412.  
 
 124 
 
53. Mathee, K, Ciofu, O, Sternberg, C, Lindum, PW, Campbell, JI, Jensen, P, 
Johnsen, AH, Givskov, M, Ohman, DE, Molin, S, Hoiby, N, Kharazmi, A. 1999. 
Mucoid conversion of Pseudomonas aeruginosa by hydrogen peroxide: a mechanism 
for virulence activation in the cystic fibrosis lung. Microbiology. 145 ( Pt 6):1349-1357.  
 
54. Medvedev, AE, Flo, T, Ingalls, RR, Golenbock, DT, Teti, G, Vogel, SN, Espevik, 
T. 1998. Involvement of CD14 and complement receptors CR3 and CR4 in nuclear 
factor-kappaB activation and TNF production induced by lipopolysaccharide and group 
B streptococcal cell walls. J Immunol. 160(9):4535-42.  
 
55. Mellata, M, Dho-Moulin, M, Dozois, CM, Curtiss, R,3rd, Lehoux, B, Fairbrother, 
JM. 2003. Role of avian pathogenic Escherichia coli virulence factors in bacterial 
interaction with chicken heterophils and macrophages. Infect. Immun. 71(1):494-503.  
 
56. Monick, MM, Mallampalli, RK, Bradford, M, McCoy, D, Gross, TJ, Flaherty, DM, 
Powers, LS, Cameron, K, Kelly, S, Merrill, A,Jr, Hunninghake, GW. 2004. 
Cooperative prosurvival activity by ERK and Akt in human alveolar macrophages is 
dependent on high levels of acid ceramidase activity. J Immunol. 173(1):123-35.  
 
57. Nagao, G, Ishii, K, Hirota, K, Makino, K, Terada, H. 2011. Role of lipid rafts in 
innate immunity and phagocytosis of polystyrene latex microspheres. Colloids Surf. B 
Biointerfaces. 84:317-324. doi: 10.1016/j.colsurfb.2011.01.018; 
10.1016/j.colsurfb.2011.01.018.  
 
58. Nguyen, DH, Catling, AD, Webb, DJ, Sankovic, M, Walker, LA, Somlyo, AV, 
Weber, MJ, Gonias, SL. 1999. Myosin light chain kinase functions downstream of 
Ras/ERK to promote migration of urokinase-type plasminogen activator-stimulated cells 
in an integrin-selective manner. J. Cell Biol. 146:149-164.  
 
59. Nivens, DE, Ohman, DE, Williams, J, Franklin, MJ. 2001. Role of alginate and its 
O acetylation in formation of Pseudomonas aeruginosa microcolonies and biofilms. J. 
Bacteriol. 183(3):1047-57.  
 
60. Oglesby, LL, Jain, S, Ohman, DE. 2008. Membrane topology and roles of 
Pseudomonas aeruginosa Alg8 and Alg44 in alginate polymerization. Microbiology. 
154:1605-1615. doi: 10.1099/mic.0.2007/015305-0; 10.1099/mic.0.2007/015305-0.  
 
 125 
 
61. Ohman, DE, Chakrabarty, AM. 1981. Genetic mapping of chromosomal 
determinants for the production of the exopolysaccharide alginate in a Pseudomonas 
aeruginosa cystic fibrosis isolate. Infect. Immun. 33(1):142-8.  
 
62. O'Toole, GA, Kolter, R. 1998. Initiation of biofilm formation in Pseudomonas 
fluorescens WCS365 proceeds via multiple, convergent signalling pathways: a genetic 
analysis. Mol. Microbiol. 28:449-461.  
 
63. Pier, GB, Coleman, F, Grout, M, Franklin, M, Ohman, DE. 2001. Role of alginate 
O acetylation in resistance of mucoid Pseudomonas aeruginosa to opsonic 
phagocytosis. Infect. Immun. 69:1895-1901. doi: 10.1128/IAI.69.3.1895-1901.2001.  
 
64. Pils, S, Schmitter, T, Neske, F, Hauck, CR. 2006. Quantification of bacterial 
invasion into adherent cells by flow cytometry. J. Microbiol. Methods. 65:301-310. doi: 
10.1016/j.mimet.2005.08.013.  
 
65. Redente, EF, Orlicky, DJ, Bouchard, RJ, Malkinson, AM. 2007. Tumor signaling 
to the bone marrow changes the phenotype of monocytes and pulmonary macrophages 
during urethane-induced primary lung tumorigenesis in A/J mice. Am. J. Pathol. 
170:693-708. doi: 10.2353/ajpath.2007.060566.  
 
66. Robles-Price, A, Wong, TY, Sletta, H, Valla, S, Schiller, NL. 2004. AlgX is a 
periplasmic protein required for alginate biosynthesis in Pseudomonas aeruginosa. J. 
Bacteriol. 186:7369-7377. doi: 10.1128/JB.186.21.7369-7377.2004.  
 
67. Rubin, BK. 2007. Mucus structure and properties in cystic fibrosis. Paediatr Respir 
Rev. 8(1):4-7.  
 
68. Ruhen, RW, Holt, PG, Papadimitriou, JM. 1980. Antiphagocytic effect of 
Pseudomonas aeruginosa exopolysaccharide. J. Clin. Pathol. 33(12):1221-2.  
 
69. Ryder, C, Byrd, M, Wozniak, DJ. 2007. Role of polysaccharides in Pseudomonas 
aeruginosa biofilm development. Curr. Opin. Microbiol. 10:644-648. doi: 
10.1016/j.mib.2007.09.010.  
 
 
 126 
 
70. Sadikot, RT, Blackwell, TS, Christman, JW, Prince, AS. 2005. Pathogen-host 
interactions in Pseudomonas aeruginosa pneumonia. Am. J. Respir. Crit. Care Med. 
171:1209-1223. doi: 10.1164/rccm.200408-1044SO.  
 
71. Schepetkin, IA, Quinn, MT. 2006. Botanical polysaccharides: macrophage 
immunomodulation and therapeutic potential. Int. Immunopharmacol. 6:317-333. doi: 
10.1016/j.intimp.2005.10.005.  
 
72. Sheppard, DN. 2011. Cystic fibrosis: CFTR correctors to the rescue. Chem. Biol. 
18:145-147. doi: 10.1016/j.chembiol.2011.02.003.  
 
73. Sikkeland, LI, Kongerud, J, Stangeland, AM, Haug, T, Alexis, NE. 2007. 
Macrophage enrichment from induced sputum. Thorax. 62:558-559. doi: 
10.1136/thx.2006.073544.  
 
74. Speert, DP, Wright, SD, Silverstein, SC, Mah, B. 1988. Functional 
characterization of macrophage receptors for in vitro phagocytosis of unopsonized 
Pseudomonas aeruginosa. J. Clin. Invest. 82(3):872-9.  
 
75. Stringer, B, Imrich, A, Kobzik, L. 1995. Flow cytometric assay of lung macrophage 
uptake of environmental particulates. Cytometry. 20:23-32. doi: 
10.1002/cyto.990200106.  
 
76. Sun, X, Wang, X, Chen, T, Li, T, Cao, K, Lu, A, Chen, Y, Sun, D, Luo, J, Fan, J, 
Young, W, Ren, Y. 2010. Myelin activates FAK/Akt/NF-kappaB pathways and provokes 
CR3-dependent inflammatory response in murine system. PLoS One. 5(2):e9380. doi: 
10.1371/journal.pone.0009380.  
 
77. Tabary, O, Zahm, JM, Hinnrasky, J, Couetil, JP, Cornillet, P, Guenounou, M, 
Gaillard, D, Puchelle, E, Jacquot, J. 1998. Selective up-regulation of chemokine IL-8 
expression in cystic fibrosis bronchial gland cells in vivo and in vitro. Am. J. Pathol. 
153:921-930. doi: 10.1016/S0002-9440(10)65633-7.  
 
78. Tart, AH, Blanks, MJ, Wozniak, DJ. 2006. The AlgT-dependent transcriptional 
regulator AmrZ (AlgZ) inhibits flagellum biosynthesis in mucoid, nonmotile 
Pseudomonas aeruginosa cystic fibrosis isolates. J. Bacteriol. 188(18):6483-9.  
 
 127 
 
79. Tart, AH, Wolfgang, MC, Wozniak, DJ. 2005. The alternative sigma factor AlgT 
represses Pseudomonas aeruginosa flagellum biosynthesis by inhibiting expression of 
fleQ. J. Bacteriol. 187(23):7955-62.  
 
80. Thieblemont, N, Haeffner-Cavaillon, N, Haeffner, A, Cholley, B, Weiss, L, 
Kazatchkine, MD. 1995. Triggering of complement receptors CR1 (CD35) and CR3 
(CD11b/CD18) induces nuclear translocation of NF-kappa B (p50/p65) in human 
monocytes and enhances viral replication in HIV-infected monocytic cells. J. Immunol. 
155:4861-4867.  
 
81. Tombolini, R, Unge, A, Davey, ME, de Bruijn, FJ, Jansson, JK. 1997. Flow 
cytometric and microscopic analysis of GFP-tagged Pseudomonas fluorescens bacteria. 
FEMS Microbiol Ecol. 22:17-28.  
 
82. Tsuchiya, S, Kobayashi, Y, Goto, Y, Okumura, H, Nakae, S, Konno, T, Tada, K. 
1982. Induction of maturation in cultured human monocytic leukemia cells by a phorbol 
diester. Cancer Res. 42(4):1530-6.  
 
83. Ueda, Y, Hirai, S, Osada, S, Suzuki, A, Mizuno, K, Ohno, S. 1996. Protein kinase 
C activates the MEK-ERK pathway in a manner independent of Ras and dependent on 
Raf. J. Biol. Chem. 271:23512-23519.  
 
84. Underhill, DM, Goodridge, HS. 2012. Information processing during phagocytosis. 
Nat. Rev. Immunol. 12:492-502. doi: 10.1038/nri3244; 10.1038/nri3244.  
 
85. von Bismarck, P, Winoto-Morbach, S, Herzberg, M, Uhlig, U, Schutze, S, 
Lucius, R, Krause, MF. 2012. IKK NBD peptide inhibits LPS induced pulmonary 
inflammation and alters sphingolipid metabolism in a murine model. Pulm. Pharmacol. 
Ther. 25:228-35. doi: 10.1016/j.pupt.2012.03.002.  
 
86. Walker, TS, Tomlin, KL, Worthen, GS, Poch, KR, Lieber, JG, Saavedra, MT, 
Fessler, MB, Malcolm, KC, Vasil, ML, Nick, JA. 2005. Enhanced Pseudomonas 
aeruginosa biofilm development mediated by human neutrophils. Infect. Immun. 
73(6):3693-701.  
 
 
 128 
 
87. Wood, LF, Leech, AJ, Ohman, DE. 2006. Cell wall-inhibitory antibiotics activate the 
alginate biosynthesis operon in Pseudomonas aeruginosa: Roles of sigma (AlgT) and 
the AlgW and Prc proteases. Mol. Microbiol. 62:412-426. doi: 10.1111/j.1365-
2958.2006.05390.x.  
 
88. Yang, D, Jones, KS. 2009. Effect of alginate on innate immune activation of 
macrophages. J. Biomed. Mater. Res. A. 90:411-418. doi: 10.1002/jbm.a.32096.  
 
89. Zhou, H, Liao, J, Aloor, J, Nie, H, Wilson, BC, Fessler, MB, Gao, HM, Hong, JS. 
2013. CD11b/CD18 (Mac-1) is a novel surface receptor for extracellular double-
stranded RNA to mediate cellular inflammatory responses. J. Immunol. 190:115-125. 
doi: 10.4049/jimmunol.1202136; 10.4049/jimmunol.1202136.  
 
  
  
 129 
 
 
 
 
 
 
Vita 
 
 
 
Warren James Rowe III was born on August 27, 1985, in Baltimore, Maryland and is an 
American citizen. He graduated from Stephen Decatur High School in Berlin, Maryland 
in 2003. He received a Bachelor of Science degree in Cellular & Molecular Biology and 
Genetics, with a minor in Astronomy, from the University of Maryland in College Park, 
Maryland in 2007. Warren began graduate school at Virginia Commonwealth University 
in Richmond, Virginia in 2008, and joined the laboratories of Dr. Ohman and Dr. 
Lebman in 2009. 
